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This study used a prospective cohort design. A simple questionnaire was 
developed asking about family history o f pregnancy hypertension in
As the purpose o f the study was to assess the value o f information provided 
by the women themselves in predicting PIH no attempt was made to verify 
information given, by tracing case records o f family members. Case
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Summary
Pregnancy-induced hypertension (PIH) is a common complication affecting 
approximately 20% of women. Despite improved health o f women and the 
availability o f antenatal care, it remains a major cause o f maternal mortality 
and perinatal morbidity and mortality. The condition has been recognised 
for centuries, however its aetiology remains uncertain. Numerous studies
have suggested that familial factors are associated with susceptibility to
develop PIH, although the genetic basis of the condition is not clear.
The purpose o f this study is to investigate the value o f a family history o f  
hypertension in pregnancy or cardiovascular disease, as reported by the 
woman herself in predicting the development o f PIH.
.The sample consisted o f 1181 primigravid women who booked for 
.antenatal care, within the first trimester o f pregnancy, at Glasgow Royal 
Maternity Hospital. Following return o f a self report questionnaire and 
collection o f data on pregnancy outcome, complete data was available for 
955 women.
mothers, sisters, aunts and grandmothers. Additional questions were asked 
about the occurrence o f cardiovascu 
and stroke) in close family members.
lar disease (hypertension, heart disease
I
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records o f all women entered into the study were followed up for outcome 
o f pregnancy.
Data were analysed for overall incidence o f PIH and in particular for 
incidence in groups o f women who reported either positive or negative 
family history o f hypertension in pregnancy or cardiovascular disease.
The study found that the incidence o f a reported family history o f  
pregnancy hypertension was high (35.7%). The incidence o f reported 
family history o f cardiovascular disease was also high (49.1%). In contrast 
the incidence o f PIH, in particular severe disease, within women in the 
study was low (14% for all PIH, 1.4% for severe).
The odds ratio for development o f mild PIH and for PIH requiring therapy 
were significantly increased in women who reported that a member o f  their 
family had been affected by pregnancy hypertension compared to those who 
reported that they had no such history (1.56 and 2.0 respectively). 
However the odds ratio was not significantly increased for women who 
developed moderate and severe disease.
The questionnaire also identified a group o f women who reported that they 
had no family history o f disease. The incidence o f PIH amongst these 
women was significantly lower than that in women who reported that they 
had a family history o f  either pregnancy hypertension or cardiovascular 
disease (11.1% versus 15%). Women who reported that they had a sister 
who had been affected had a particularly high incidence o f PIH (28.5%) 
When this group was compared to the women who reported no family 
history the odds ratio was significantly increased for development o f all 
types o f PIH. However in the more clinically meaningful comparison with
.M.i/
the study group as a whole the odds ratio was only significantly increased in 
relation to mild disease.
The study investigated the affect o f a reported family history o f  
cardiovascular disease on development o f PIH. In comparison with the 
group o f women who reported no history, women who gave a family 
history o f essential hypertension had an increased odds ratio for 
development o f PIH, in particular mild disease (odds ratio 1.97). Those 
who gave a family history o f cardiac disease had an increased odds ratio 
(2.27) for moderate and severe disease.
Information provided by women themselves on family history o f pregnancy 
hypertension and cardiovascular disease did identify risk groups for 
subsequent development o f PIH. In a clinical setting this information may 
be o f value as part o f an assessment o f  individual women's risk o f  
developing PIH and in planning antenatal care. However, even within the 
highest risk group the incidence o f severe PIH remained low, most women 
remaining normal throughout pregnancy. Correspondingly within the 
lowest risk group, although the incidence of severe disease was low it did 
occur in some women. Based on the data o f this study it would appear that 
information on family history o f pregnancy hypertension or cardiovascular 
disease, provided by the woman herself would not be o f clinical value as a 
screening test for predicting the development o f PIH. The questionnaire 
was acceptable to most women within the study, and may be useful in 
identifying affected family groups for further research into the genetic basis 
ofPIH.
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Introduction
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1.1 The problem of pregiiaiicy-iiidiiced hypertension (PIH) and 
purpose of research
l . L i  A womcm's experience o f  PIH
"I developed pre-edampsia a! fhirly weeks and a! Ihirty-one 
weeks I had an emergency section as my blood pressure was so 
high they thought I was going to die. Do you know, I  went to 
my doctor at thirty weeks and he said /  had mild toxaemia and 
to go home and put my feet up. 1 he following week my blood 
pressure was 150/110 they suggested I stay in hospital, I came 
back in the evening and went into a coma. I looked like I had 
been pumped up with a bicycle pump I was so swollen, the 
whole thing was a nightmare. My son weighed three pounds 
two ounces, he lived for three days. "
(Anon; 1990)
The effects o f hypertension in pregnancy have been recognised since the 
time o f ancient Greece. Numerous terms have been used to identify the 
condition, however, its aetiology remains largely unknown today.
PIH, despite improvements in ante natal and intrapartum care, continues to 
be one o f the main causes o f maternal mortality and is a major cause o f  
perinatal morbidity and mortality (Chamberlain et al, 1978; MacGillivray, 
1983).
1.1.2 Prediction o f PIH
PIH is a condition which primarily affects primigravid women, as such it 
cannot be predicted on the basis o f past histoi-y o f the disease. It occurs in 
the second half o f pregnancy and onset is often severe and without warning,
■'Si.:
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A successful screening test would improve the targeting o f monitoring for 
women at risk o f developing the disorder and give opportunity for 
prophylaxis, should this be successfully developed, or o f early treatment. 
For this reason many screening tests for PIH have been developed, but 
none have as yet been shown to be practical, effective and cost effective.
1. L 3 Familial tendency to PIH
It is thought that PIH occurs in susceptible women and several researchers 
have suggested that there is a familial tendency in its development. 
Chesley, Cosgrove and Annitto (1968) brought together a number o f  
reports, the earliest dating from the end o f the last century which describe 
families where numerous members have been affected by eclampsia and 
pre-eclampsia. Many o f these descriptive studies have relied at least in 
part, on anecdotal information and in addition, have included both 
primigravid and parous women and so may include those with essential 
hypertension as well as PIH and eclampsia. Chesley, Cosgrove and Annitto 
(1961, 1968, 1976) reported the systematic follow-up, using medical 
records, of the families o f a group o f women who had survived eclampsia 
between 1931 and 1951. They reported an increase in the incidence o f both 
eclampsia and pre-eclampsia in the sisters and daughters o f  the index cases 
compared to the general population. Subsequent studies have attempted to 
determine to genetic basis o f PIH and eclampsia (Cooper and Liston, 1979; 
Chesley and Cooper, 1986; Kilpatrick, 1987; Cooper et al, 1988; 
Arngrimsson et al, 1990), although it remains unclear whether the genetic 
model is dependent on maternal genotype or on maternal-fetal genetic 
interaction. All these studies agree however, that the predisposition to PIH 
is heritable and this gives the possibility that knowledge o f a woman's 
family history may be o f use in predicting women at risk o f  developing PIH.
14
L L 4  Purpose o f  research
This thesis describes a study carried out at Glasgow Royal Maternity 
Hospital. The aim o f this study was to test the value o f the knowledge o f a 
family history o f hypertension in pregnancy or cardiovascular disease, as 
reported by the woman herself, as a predictor o f the development o f PIH.
The Royal Maternity Hospital serves the north and east o f  the city o f  
Glasgow. This area has a more transient population, than that studied in 
Iceland by Arngrimsson et al (1990). It is difficult to trace the obstetric 
case records o f the family members o f many women who are cared for at 
Glasgow Royal Maternity Hospital. This is due partly to the frequent 
surname changes o f many families, the wide dispersal o f family members, 
the closure o f small maternity homes within the city over the past 20 years, 
and the distribution or destruction o f case records from these homes. To 
attempt to obtain information on family history by tracing old medical 
records is time consuming and often fruitless. The principle o f a screening 
test is that it is simple and cost effective to apply to a large population with 
the aim of detecting the small number who will be at high risk o f being 
affected by the condition. We therefore sought to find out what 
information women themselves could give about their family history and to 
evaluate its usefulness in predicting their risk o f developing PIH. We did 
this by means o f self completed questionnaire. The aim was to develop a 
family history questionnaire which was easy to administer and complete, 
and to test this as a screening test for susceptibility to the development o f  
PIH.
6  i 3!'. !,     .
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1.2 Aim of research
To determine whether family history o f hypertension in pregnancy or 
cardiovascular disease, as reported by the woman herself, is a predictor in 
the development o f PIH.
1.3 Objectives of research
i) To determine the self reported incidence o f hypertension in pregnancy in 
the family history o f the study group.
ii) To determine the incidence o f PIH and pre-eclampsia in the study group.
iii) To determine whether a self reported family history o f hypertension in 
pregnancy predicts women at risk o f PIH.
iv) To determine the self reported incidence o f cardiovascular disease in the 
family history o f the study group.
v) To determine if a self reported history o f cardiovascular disease predicts 
women at risk o f PIH.
vi) To determine whether absence o f a self reported family history o f  
hypertensive disease selects a group at low risk for the development o f  
PIH.
vii) To determine if a self completion questionnaire is a feasible tool for 
gaining information on the family history o f women booking at an ante 
natal clinic.
__________________
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1.4 Literature review
1.4.1 History o f  Pre-eclampsia.
The effects o f pre-eclampsia have been recognised for centuries. As 
knowledge o f the condition has grown its various signs have been 
attributed to various diseases, in particular; epilepsy, renal disease and 
essential hypertension.
1.4.2 Epilepsy
From the earliest times it has been known that convulsions may affect 
women in pregnancy. Chesley (1978) reviewed the earliest history o f 
eclampsia and the development o f  medical understanding o f the condition, 
the following summary is based largely on this work. In his review Chesley 
suggests that the Greeks, prior to Hippocrates time may have recognised 
pre-eclampsia, in that a pregnant woman suffering drowsy headaches with 
heaviness was considered liable to suffer fits.
Hippocrates in his Aphorisms (Sec, vi, No 30) wrote that
'77 proves fa ta l to a woman in the state o f  pregnancy i f  
she he seized with any o f  the acute diseases”
Six centuries later Gallen commenting on these aphorisms writes that 
epilepsy, apoplexy, convulsions and tetanus are especially lethal.
Gabelchoverus in 1596 noted pregnancy to be one o f  four causes o f  
epilepsy. A century later Mauriceau attributed convulsions in pregnancy to 
an excess o f heated blood, irritation o f the uterine cervix or to noxious 
vapours arising from the uterus when the fetus had died. He recognised 
that primigravid women were at far greater risk o f convulsions than 
multiparas, a factor considered o f importance today.
17
L 4.3 Eclampsia
It was not until the 18th century that it was appreciated that eclampsia and 
epilepsy were different diseases. De Sauvages in 1739 differentiated 
epilepsy, a chronic condition, from convulsions o f acute causes which he 
termed eclampsia. One o f these being described as Eclampsia 
parturientium. Eclampsia continued to be used as a generic term for 
convulsions o f various causes. This persisted until the early 1960's when all 
but the obstetric definition was dropped (Chesley, 1978).
L 4.4 Renal disease
In 1843, Lever found that women with eclampsia had proteinuria and for 
many years renal disease was thought to be the cause o f eclampsia. Lever 
acknowledged that eclampsia was different from renal disease in that 
proteinuria resolved after delivery. With the development o f  methods o f  
assessing renal function, and the renal histology studies o f Sheehan in 1950 
it was demonstrated that renal lesions were present only when a patient had 
proteinuria. This is a late manifestation o f the disease and therefore it was 
apparent that renal disease was not a primary cause o f the condition.
1.4.5 Hypertension
The development o f blood pressure recording techniques in the late 
nineteenth and early twentieth centuries led to the discovery that 
hypertension is associated with eclampsia (Cook and Briggs, 1903) and the 
term pre-eclampsia was introduced to describe the condition o f  
hypertension prior to a convulsion occurring.
Primary or essential hypertension was differentiated from renal 
hypertension in 1896 and was termed "senile plethora" (Ballantyne, 1885).
i lE l.....................        .■
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This was considered to be a disease o f the elderly and therefore could not 
present in a woman o f childbearing age. It was not until the 1940's 
(Chesley, 1980) that essential hypertension was accepted as a possible 
cause o f hypertension in pregnancy.
Chesley et al (1976) followed the medical histories o f a group o f women 
who had suffered from eclampsia. This study covering a period o f over 40 
years demonstrated that there was a hypertensive condition, specific to 
pregnancy which resolved at the end o f the pregnancy and carried no long 
term sequalae.
1.4.6 Types o f Hypertension.
At the present time it appears that here are two main types o f hypertension 
which affect women in pregnancy (Wallenburg, 1989; Walker, 1991).
i) Pregnancy occurring in women with pre-existing chronic 
(essential) hypertension, renal disease or other hypertensive disease 
diagnosed prior to pregnancy. This may be detected in the first 
trimester o f pregnancy or when hypertension persists following 
delivery.
ii) Hypertension which occurs for the first time during the second 
half o f pregnancy, labour or puerperium and which resolves when 
the pregnancy is over. This condition occurs predominantly, but 
not exclusively in primigravida. There are various terms for this 
condition, but the most commonly used are pregnancy - induced 
hypertension (PIH) and pre-eclampsia. (Greer, 1992)
19
L 4.7 Defming signs
Since the aetiology o f PIH and pre-eclampsia is unknown, the definition 
and diagnosis are based on the three classical clinical signs, hypertension, 
proteinuria and oedema.
i) Hypertension
During the first trimester o f a healthy pregnancy there is a 40% increase in 
maternal blood volume and increased cardiac output which will be 
maintained throughout the pregnancy. In order to compensate for this 
there is normally vasodilation and therefore decreased peripheral vascular 
resistance. There is a decrease in arterial blood pressure which is greatest 
during mid pregnancy after which the blood pressure tends to rise again 
toward the non pregnant level approaching term (MacGillivray, Rose and 
Rowe, 1969; Page and Christianson, 1976). In PIH the blood pressure 
increases as a result o f an increased systemic vascular resistance in the 
presence o f the increased cardiac output which has occurred in the first 
trimester o f pregnancy. Hypertension is not the disorder in itself, but rather 
an indication o f an underlying circulatory disturbance (Wallenburg, 1989), 
and as such, may be used as a marker o f  risk. The traditional dividing line 
between normal and abnormal blood pressure in pregnancy is a diastolic 
blood pressure o f 90mmHg (Greer, 1992) using KorotkofF phase IV as the 
measure o f diastolic pressure. Although, for some women, towards term 
this may not reflect a particularly substantial rise in blood pressure from 
their pre-pregnancy level. Studies have shown, however, that there is an 
increased perinatal mortality rate where the mothers blood pressure rises 
above 90mmHg (Page and Christianson, 1976).
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ii) Proteinuria
In pregnancy, proteinuria is considered abnormal when it reaches a level 
greater than 300mg in 24 hours. The absence o f proteinuria does not 
always ensure that PIH will be mild, as severe PIH may occur in the 
absence o f proteinuria and the correlation between the level o f blood 
pressure and the occurrence o f proteinuria is low (McEwan, 1987), Where 
it is present however, proteinuria is a sign o f severe disease and is 
associated with an increase in perinatal mortality (MacGillivray, 1958; 
Friedman and N eff 1976).
iii) Oedema
Although oedema is one o f the classic signs of pre-eclampsia it also 
frequently occurs in normotensive pregnancies (Robertson, 1971). In the 
absence o f hypertension and proteinuria it is not associated with poor 
perinatal outcome. Oedema does occur in about 85% of women with pre­
eclampsia (Thomson, Hytten and Billewicz, 1967). Unlike hypertension 
and proteinuria however, oedema is not a marker o f disease severity. 
Interestingly, oedema in pre-eclampsia is associated with a lower perinatal 
mortality rate than pre-eclampsia with no oedema so called dry pre- 
eclampsid (Vosburgh, 1976), and is o f no value as a defining sign o f PIH.
1.4.8 Definilion
Nelson's definition (1955) o f pre-eclampsia has traditionally been widely 
accepted as follows:
Mild pre-eclampsia; a diastolic blood pressure o f 90mmlig or over, on two 
occasions at least 24 hours apart, occurring for the first time after twenty- 
six weeks gestation, where there is no evidence of pre-existing hypertensive 
disease.
;4Î;
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Severe pre-eclampsia; in addition to raised blood pressure as described 
there is proteinuria o f at least 0.3g/litre in twenty-four hours.
A similar definition accepted by the International Society for the Study o f  
Hypertension in Pregnancy uses the term PIH which may be mild, moderate 
or severe.
PIH is diagnosed where a diastolic blood pressure o f 90mmHg or greater, 
occurs in a previously normotensive woman after the 20th week o f  
pregnancy, two consecutive recordings having been obtained at least four 
hours apart (Davey and MacGillivray, 1986). Many authors classify mild 
and moderate PIH together, however they are differentiated clinically.
Moderate hypertension may be indicative o f disease progression and 
treatment may be commenced where PIH is classed as moderate. Collins 
and Wallenburg (1989) define moderate PIH as a systolic blood pressure 
greater than 140mmHg or diastolic blood pressure greater than 90mmHg 
on two occasions before 28 weeks gestation, or a systolic blood pressure 
greater than ISOmmHg or diastolic blood pressure greater than 95mmHg 
between 28 and 36 weeks gestation. Severe disease may be diagnosed 
where the diastolic blood pressure is persistently elevated to above 
llOmmHg. The term pre-eclampsia is only used where there is PIH with 
the addition o f proteinuria greater than 300mg in 24 hours (Davey and 
MacGillivray, 1986).
In practice, the clinical picture is often unclear. Many women will have 
their blood pressure recorded for the first time in pregnancy and, due to the 
physiological drop in blood pressure during the mid trimester o f pregnancy 
(MacGillivray, Rose and Rowe, 1969; Christianson, 1976; Chesley 1978) 
essential hypertension may be misdiagnosed as PIH when the blood 
pressure rises to the pre-pregnancy level towards term.
 : :    ' ' '
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In addition, a woman who has essential hypertension may develop 
superimposed PIH, described as an exacerbation o f hypertension or the 
development o f proteinuria or raised uric acid levels (Walker, 1992a) 
Accurate diagnosis o f PIH and pre-eclampsia is complex and may often 
only be made in retrospect.
1.4.9 The importance o f  classification
Accurate classification o f the disorder is o f primary importance where a 
distinct group is required for study or in order to compare research findings 
(Baker and Broughton Pipkin, 1993).
Nelson (1955) stresses the importance o f  adherence to simple criteria which 
may be applied rigidly in any investigation into the epidemiology o f pre­
eclampsia,
'so that there is no temptation fo r  the investigator to use his 
"judgement”. The latter may change during the course o f  the 
enquiry and lead to inconsistencies o f diagnosis and grading. '
For this reason aetiological studies on hypertension in pregnancy, which are 
confined to proteinuric hypertension presenting for the first time in a 
primigravid pregnancy, will give the most clearly distinct study group.
1.4.10 Incidence
The incidence o f hypertensive disorders in pregnancy varies between 
countries, racial groups (Tunbridge and Donnai, 1983) and clinical centres. 
This may be explained partly by the wide variation in health care available 
to women in different areas, and partly to the lack o f conformity in the 
terminology and definitions used to classify the hypertensive disorders in 
pregnancy (Greer, 1992).
______________________________________
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A study o f primigravid women in Aberdeen during the years 1948-1955 
(MacGillivray, 1958) investigated the incidence of pre-eclampsia in the first 
and second pregnancies of the same women. Using Nelson's definition o f 
pre-eclampsia, this study reported an incidence in the first pregnancy o f Si
18.4% for mild pre-eclampsia and 5.8% for severe pre-eclampsia. S
Where the first pregnancy was normotensive, only 3.1% of women 
developed mild pre-eclampsia and 0.1% severe pre-eclampsia, in their 
second pregnancy. This study concludes that pre-eclampsia is primarily a h|
disease o f the first pregnancy and that a normal first pregnancy protects the siwoman from pre-eclampsia in subsequent pregnancies.
' I
A second study carried out in Aberdeen whicii studied a total population o f r | |
pregnant women between 1967 to 1978 (Campbell and MacGillivray, 1985) |
reported a higher incidence o f mild pre-eclampsia, 26.3% and a similar SSI
incidence 5.6% for severe pre-eclampsia in primigravidae. The authors 
suggest that this increased incidence o f mild pre-eclampsia could reflect the 
greater availability o f blood pressure tests at this time. This study found 
that considering all second pregnancies there was an incidence o f 17% mild 
pre-eclampsia and 1,9% severe pre-eclampsia.
Further investigating the incidence o f pre-eclampsia in the second 
pregnancy according to the presence and degree o f the disease in the first 
pregnancy, it was found that women who had proteinuric pre-eclampsia in 
their first pregnancy had an increased risk of both mild and severe disease in 
a second pregnancy, 30.1% mild, 7.5% severe. Only 2% o f women who 
had mild pre-eclampsia in their first pregnancy developed severe pre­
eclampsia in their second pregnancy, although 29% of women within this 
group developed mild pre-eclampsia in their second pregnancy. Where a 
woman has a normotensive first pregnancy the incidence o f both mild and
24
severe pre-eclampsia in a second pregnancy is low, 9.3% and 0.7% 
respectively.
More recent studies in European and American populations have reported a 
lower incidence o f pre-eclampsia than that reported in the Aberdeen studies 
(Alderman, Sperling and Baling, 1986; Kilpatrick et al, 1989). The 
incidence reported in these studies has been between two and three per 
cent. The reason for the apparent reduction in pre-eclampsia is not entirely 
clear, however, Kilpatrick et al (1989) suggest that one factor may be the 
reliance on current hospital records, which may have reduced diagnostic 
error.
1.4.11 Maternal risk o f  PIH
i) Maternal death
There has been a fall in the number o f deaths attributable to PIH and 
eclampsia compared to 30 years ago, however, they remain the major cause 
of maternal death in the United Kingdom (Department o f Health, 1989). 
Pulmonary oedema, cerebral vascular accident and cerebral oedema are the 
commonest causes o f death (Turnbull et al, 1989). Death associated with 
PIH and eclampsia may also be caused by liver damage, disseminated 
intravascular coagulation or renal failure.
ii) Eclampsia
Eclampsia is identified by grand mal seizures in the absence o f  epilepsy or 
other cause o f  convulsions. The terms pre-eclampsia and eclampsia imply 
that there is an inevitable progression from the other, however, many 
women will be asymptomatic prior to the onset o f convulsions. About 50% 
of cases o f eclampsia occur antenatally during the second half o f pregnancy,
i:
-M'-' ; j . . z : l i .  L   : _______ :__ :______ L . : ___
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25% of cases will occur during labour and the remaining 25% will occur 
during the puerperium (Villar and Sibai, 1988).
Hypertension and proteinuria are usually associated with eclampsia 
although the hypertension may not be severe and proteinuria is absent in 20 
to 40% of cases (Walker, 1992a; Villar and Sibai, 1988). The most 
common prodromal symptoms are headache, epigastric pain and visual 
disturbance (Sibai, El-Nazir and Gonzalez-Ruiz, 1986), O f women who 
develop eclampsia the main cause o f death is cerebral haemorrhage 
although most eclamptic women present with no evidence o f hypertension 
prior to the convulsion (Walker, 1992b).
iii)Abruption
Traditionally PIH has been associated with an increased risk o f placental 
abruption. Fifty years ago 75% of cases o f abruption were associated with 
hypertension (Munro Kerr, 1933). Although more recent studies have 
shown that two thirds of cases of abruption occur in normotensive 
pregnancies (Chamberlain, 1981), the risk o f abruption is still almost three 
times greater in severe PIH than in normotensive pregnancies (Sibai et al, 
1986).
iv) Essential hypertension
Studies such as that by Chesley et al, (1976) and Fisher et al (1981) 
followed up, over a lengthy period, groups o f women who had developed 
eclampsia or PIH and reported the incidence of essential hypertension in 
later life was no greater than would be found in the general population.
For several groups, however there does appear to be an increased incidence 
o f hypertension in later life, these are women who develop severe PIH or 
eclampsia particularly where this presents prior to 30 weeks gestation.
: : ■fi-1^-
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those who have hypertension in several pregnancies (Sibai et al, 1986) and 
women who have mild PIH (Greer, 1992). It may be that these women 
have a tendency to essential hypertension which is first manifest during 
pregnancy.
L4. I2 Risk to the fe ins from  PIH
Proteinuria in association with hypertension and eclampsia, gives an 
increased perinatal mortality rate o f 33.7/1000 compared with 19.2/1000 in 
normotensive pregnancies (Chamberlain et al, 1978). Severe PIH and 
eclampsia are also associated with intrauterine growth retardation (lUGR) 
and intrauterine asphyxia (Moore and Redman, 1983). The baby who is not 
affected by intrauterine growth retardation is still at risk from prematurity 
where delivery is carried out in the mother's interest regardless of gestation. 
In the longer term there is an association between severe pre-eclampsia and 
neurodevelopmental disability (Taylor, 1988).
Î.4 .13 Pathology
The maternal circulatoiy changes which occur during pregnancy are not 
completely understood. They are associated with the interaction o f fetal 
and maternal tissue which leads to the vascular adaptations to pregnancy 
occurring in the uteroplacental bed. It is not clear why in PIH there is 
failure to develop the normal circulatory adaptation to pregnancy. Cooper, 
Brennecke and Wilton (1993) summarise the pathology o f PIH as follows. 
They suggest that it may originate from a genetic defect which causes 
dysfunction in the maternal immunological adaptation to the presence o f the 
fetus, leading to exposure o f the trophoblast to a damaging maternal 
immunological reaction in the developing placental site. There is failure o f 
trophoblast invasion o f maternal placental bed spiral arteries, with placental 
bed vascular atherosis which results in placental tissue ischaemia. This is
________
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follo wed by release o f a toxic factor and consequential generalised maternal 
vascular endothelial cell dysfunction.
There is a reduction in the production o f vasodilator substances from the 
maternal endothelium, such as prostacyclin and an increase in 
vasoconstrictors such as endothelin. This paracrine imbalance contributes 
to vasospasm and an exaggerated response to angiotensin ÏÏ. In addition 
reduced placental perfusion leads to the formation o f microthrombi as well 
as platelet consumption in the mother, and a chronic form o f low grade 
disseminated intravascular coagulation. Increased platelet consumption is 
associated with an increase in production o f thromboxane A2 which is a 
vasoconstrictor. Tissue hypoxia from vasoconstriction, decreased tissue 
perfusion due to oedema and hypovolemia causes dysfunction o f kidney, 
liver, brain and placenta as well as other organs. This gives rise to the 
characteristic signs o f PIH, namely hypertension, proteinuria, lUGR and in 
the most severe cases, epigastric pain and eclampsia.
/. 4.14 Managemenl o f PIH
Until recently any pregnant woman presenting with a diastolic blood 
pressure o f 90mmHg or above would invariably be admitted to hospital for 
periods o f bed rest. Midwifery textbooks contained detailed instructions 
for the care o f the woman with pre-eclampsia including nursing in a 
darkened room and earplugs to reduce disturbance to the woman caused by 
noise (Myles, 1975). Today however the focus o f management of PIH is 
the assessment o f disease severity and the assessment o f fetal well-being. 
The maternal condition is assessed using serial blood pressure 
measurement, full blood and platelet count together with measurement of 
plasma urea and electrolytes, urate and liver function tests.
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Fetal well-being is assessed by ultrasound estimation o f growth, fetal heart 
rate monitoring and biophysical profile as well as Doppler ultrasound 
assessment o f umbilical blood flow (Greer, 1992). Treatment aims to 
protect the mother from the effect o f hypertension and to prolong the 
pregnancy allowing the fetus to mature and thereby reducing perinatal 
morbidity and mortality. There is agreement that antihypertensive therapy 
should be used where hypertension is severe i.e., diastolic blood pressure 
over llOmmHg, however, treatment is less well accepted in mild and 
moderate disease where the risk to the mother comes from the potential for 
disease progression rather than from hypertension itself. The aim o f  
treatment in mild and moderate disease is to reduce disease progression and 
to allow women to remain at home (Walker, 1987).
Within the Glasgow Royal Maternity Hospital a stepwise approach to the 
use of anti hypertensive therapy is used for both essential hypertension and 
PIH (Greer, 1992). This systematic approach to treatment involves the use 
o f a first line therapy such as methyldopa or an adrenocepter antagonist 
such as labetalol or atenolol. Second and if necessary third line therapy is 
used to gain, and maintain control o f the woman's blood pressure. Second 
line therapy usually takes the form o f a vasodilator such as hydralazine or 
nifedipine and third line therapy, methyldopa or an adrenocepter antagonist 
depending on the first line agent, Delivery will be carried out when an 
adequate gestation is reached or there are signs o f fetal distress or 
deterioration in the condition o f the mother.
1.4,15 Prophylaxis
Two therapies have been postulated to be effective in reducing the 
incidence o f PIH; these are low-dose aspirin (Wallenburg et al, 1986) and 
fish oil (Secher and Olsen, 1990). Aspirin suppresses the synthesis o f
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thromboxane (Collins and Wallenburg, 1989) resulting in less platelet 
aggregation which may benefit placental perfusion. Several small, 
controlled trials had suggested that aspirin reduced the incidence of 
proteinuric hypertension as well as lUGR.
A trial was designed to investigate the benefits and risks o f low dose 
aspirin, the collaborative low dose aspirin study in pregnancy (CLASP, 
1994), in which 9354 women were randomly allocated to receive either 
60mg aspirin daily or placebo. The sample size was theoretically large 
enough to detect differences in rates o f stillbirths and neonatal deaths 
between the two groups. The results o f the CLASP study showed that 
aspirin did appear to be o f benefit in preventing or delaying the need for 
delivery in early onset pre-eclampsia. However, in contrast to the findings 
o f other small controlled studies the CLASP study found only a small 
reduction in the incidence o f proteinuric pre-eclampsia, it showed no 
difference in gestation at delivery between the groups and did not affect 
intrauterine growth retardation, stillbirth or neonatal death. The results 
showed no significant increase in incidence of abruption or in bleeding 
during epidural anaesthesia and no increased morbidity in the neonate.
The results o f another large randomised controlled trial carried out by Sibai 
et al (1993), which included over 3000 women found no benefit o f aspirin 
in preventing pre-eclampsia, however this study found a significant increase 
in the incidence o f ante-partum haemorrhage in women who had received 
aspirin. The authors o f the CLASP trial conclude that available evidence 
does not support the routine prophylactic or therapeutic use o f anti-platelet 
therapy in pregnancy amongst all women thought to be at risk o f 
developing pre-eclampsia, Where there is an established increased risk o f 
severe pre-eclampsia, for example, in women who have a history of
30
severe pre-eclampsia there may be benefit from aspirin as prophylaxis in 
subsequent pregnancies.
1.4.15 Role o f antenatal care
One o f the challenges for those providing antenatal care is to differentiate 
between those women who will require medical intervention and 
monitoring in pregnancy, the "high risk" pregnancy, and the large numbers 
o f women whose pregnancies will progress with the minimum o f  
intervention.
The present system o f antenatal care has been routinely offered to all 
pregnant women since 1928 (Ministry o f Health, 1929). It is largely 
directed towards the detection o f PIH by regular measurement o f blood 
pressure and urinalysis for proteinuria. However these signs are a late 
manifestation o f the disease, usually appearing in the late second or the 
third trimester o f pregnancy and as described above (1.4.11), women 
presenting with cerebral haemorrhage or eclampsia have frequently had no 
previous evidence o f hypertension. The success o f routine antenatal care in 
prediction or early detection o f these disorders is poor. The converse 
situation is also problematic. Many women present with a diastolic blood 
pressure o f 90 mmHg in late pregnancy, they are asymptomatic and, in the 
absence o f proteinuria there is low risk to mother or fetus, however a single 
diastolic blood pressure recording o f 90mmHg often marks an action line 
for admission and increased monitoring. Hall, Chng and MacGillivray, 
(1980) suggest that as a diastolic blood pressure o f 90 mmHg at 38 to 40 
weeks gestation is within normal limits there is over diagnosis o f pre­
eclampsia at term. This study analysed the rate at which asymptomatic 
antenatal problems are diagnosed, missed or over diagnosed and reported
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that the productivity o f routine antenatal care in respect o f prediction and 
detection o f obstetric problems including pre-eclampsia is extremely low.
1.4.16 Prediction o f risk of PIH
PIH is a disease which primarily affects primigravid women. Once a 
woman has had a pregnancy complicated by PIH the risk in subsequent 
pregnancies can be predicted. Prediction o f risk in primigravidae would 
allow the possibility o f prevention or o f early detection and treatment o f the 
disease.
In the context o f health care, Hennekins and Burning (1987) define 
screening as follows;
"screening refers to the application of a test to people who 
are as yet asymptomatic for the purpose o f classifying them 
with respect to their likelihood of having a particular 
disease."
They further identify criteria for conditions appropriate for screening tests.
i) The disease should be serious.
ii) The screening test should be cost-effective in terms o f cost of 
applying the test in relation to benefit gained in prediction or early 
diagnosis.
iii) The treatment given before symptoms appear should be more 
effective than treatment given once symptoms have developed.
iv) The prevalence o f the detectable pre clinical disease should be 
sufficiently high within the target population in order to justify the 
costs o f the screening programme relative to cases detected.
PIH would appear to be a potentially suitable disease for a screening test. 
It is a serious condition, responsible for a high proportion o f maternal and 
fetal mortality and morbidity. It is a common condition in pregnancy with
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approximately 15% of primigravid women being affected, 6% developing 
severe disease (MacGillivray, 1958).
In order to be o f value a screening test must meet the following criteria; 
(Mohide and Grant, 1989). A suitable test should be valid, in terms o f 
sensitivity, specificity and reproducibility. The sensitivity o f a test is an 
index o f its ability to correctly identify the presence o f the condition, 
specificity refers to its ability to correctly exclude the condition when it is 
absent. The reproducibility o f a test refers to the consistency o f results if 
repeated tests are carried out on the same individual.
In addition to these characteristics a test should ideally be inexpensive to 
administer and acceptable to the population to be screened. Many potential 
screening tests for PIH have been identified, most are based on the principle 
that the underlying changes may be detected at a stage prior to the 
development o f the clinical signs. A few o f these tests are described below 
however as yet no effective and acceptable screening test has been 
developed.
1.4.17 Mid-trimester I)hod pressure
The use o f blood pressure recording as a means o f predicting women at risk 
o f developing PIH is attractive in that it is non invasive and is a test already 
carried out on all pregnant women who receive antenatal care. However 
there has been differing findings in studies testing the value o f mid-trimester 
blood pressure as a predictor o f PIH. A prospective study o f women of 
mixed parity by Page and Christianson (1976) suggested that mid trimester 
mean arterial blood pressure would predict the later development o f PIH. 
They found that when the average mid trimester mean arterial pressure was 
90mmHg or greater there was a significantly increased frequency o f PIH
____
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and pre-eclampsia. Subsequent studies by Moutquin et al (1985) found that 
a mid trimester mean arterial pressure o f 90mmHg gave a sensitivity o f  only 
68% a specificity o f 75% and a positive predictive value o f 14% for the 
development o f pre-eclampsia.
1.4.18 The Roll-over test
Gant et al (1974) developed the roll over test which was carried out 
between 28 and 32 weeks gestation. The women had their blood pressure 
recorded while lying on the left side and after turning onto their back. A 
positive test was noted where the diastolic blood pressure rose by more 
than 20mmHg. In this study 15 out o f the 16 women with a positive test 
subsequently developed PIH. The appeal of this test would be that it is 
simple to apply and non invasive, however, subsequent investigators have 
been unable to reproduce the high sensitivity and specificity achieved by 
Gant et al (1974). In another study using the roll-over test Turnbridge and 
Donnai (1983) reported a false negative rate o f 19% and a false positive 
rate o f 80%, this test has not been shown to be o f benefit in predicting PIH.
L 4.19 Angiotensin II infusion
In 1968, Talledo et al reported that, compared to normotensive pregnant 
women, pre-eclamptic women showed increased sensitivity to intravenous 
infusion o f angiotensin II. Subsequently in 1973, Gant et al used this 
increased sensitivity in order to predict the development o f PIH in a group 
o f 192 young primigravid women. The results o f this study showed that 
91% of the women with a negative test remained normotensive throughout 
pregnancy and, conversely only 9% o f women with a negative test 
subsequently developed PIH. Over 77% of women who had a positive test 
between 28 and 32 weeks gestation subsequently developed PIH.
The results o f other studies into the predictive value o f angeotensin II 
infusion are varied. Oney and Kaulhausen (1982) reported a high 
predictive value o f a negative test but found a false positive rate o f 
approximately 50%. Morris et al (1978) found a false positive rate o f  93% 
and a false negative rate o f 17%. Although sensitivity to angiotensin II 
infusion may be a relatively successful predictor o f the development o f PIH 
it is a time consuming and invasive test and as such is unsuitable for use as 
a screening test in the clinical situation.
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Measurement o f platelet angiotensin II binding may prove to be an effective 
proxy for angiotensin II infusion. In several studies relating to platelet 
angiotensin II binding Baker, Broughton Pipkin and Symonds (1989, 
1991a, 1991b 1992) have reported that in normotensive primigravid 
women platelet angiotensin II binding falls between five and ten weeks 
gestation paralleling the reduced sensitivity to angiotensin II. Higher levels 
o f platelet angiotensin II have been found in women with PIH compared to 
normotensive primigravid women, their hypothesis was that the difference 
in levels o f binding between normotensive and PIH would manifest before 
clinical development o f the disease.
In a small prospective study Baker et al (1992) measured platelet 
angiotensin II binding and sensitivity to angiotensin II infusion in 34 
primigravid women. They reported that there was correlation between 
platelet angiotensin II binding and sensitivity to angiotensin II infusion. In 
relation to its potential value as a predictor o f PIH they found that this test 
provided correct classification o f 77% o f women in the study. It appears 
therefore that platelet angiotensin II binding measurement may prove to be 
a successful screening test however larger studies would be required in 
order to verify the results demonstrated above.
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1.4.201 dim ilia! tendency to eclampsia and pre-eclampsia 
Since the end o f the nineteenth century there have been a number o f 
documented reports o f families where several generations have been 
affected by eclampsia and pre-eclampsia. A summaiy o f these reports has 
been drawn together by Chesley et al (1968), One such report is that by 
Brocklehurst and Ross (1960) who describe a closely inbred family in 
which there were 11 cases o f eclampsia in eight women over four 
generations.
There appears to be a familial tendency to develop PIH and eclampsia, 
although the nature o f this inheritance is not clear. A woman's 
susceptibility to develop PIH will only be tested if she becomes pregnant 
and therefore the development o f the condition could potentially be 
determined by maternal genotype alone, fetal genotype alone or by a 
maternal - fetal genotype by genotype interaction.
A number o f studies have been carried out which investigate family 
pedigrees and the development o f PIH and pre-eclampsia. In identifying 
familial patterns o f disease development the more recent studies attempt to 
identify possible genetic models. In a prospective study which covered a 
period o f fifty years Chesley traced the families of a group o f eclamptic 
women between 1931 and 1951 (Chesley et al, 1961, 1968; Chesley and 
Cooper, 1986). The lengthy time period and numerous hospitals from 
which data was collected means that terminology and criteria for 
classification may differ from that used in subsequent studies, Chesley et al 
(1961, 1968) collected data on sisters, daughters, granddaughters and 
daughters-in-law o f the index cases. In the first report o f this series he 
found that 37% of sisters o f eclamptic women had toxaemia in their first 
pregnancies and, in subsequent reports, that a diagnosis o f pre-eclampsia or
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eclampsia could be made in the first viable pregnancy o f  26.2% o f
daughters and 16.2% o f granddaughters. In the first pregnancies o f
daughters-in-law only 6.1% were diagnosed as having pre-eclampsia an 
.incidence similar to that o f the general hospital population.
In a study based in Aberdeen Maternity Hospital, Adams and Finlay son
(1961) compared the incidence o f pre-eclampsia in the sisters o f women
affected by pre-eclampsia, using Nelson's definition o f pre-eclampsia, and in
normotensive women. They found a higher incidence o f pre-eclampsia in
sisters o f affected women, 13.8% compared to 4.5% amongst the sisters o f  
,normotensive women.
'fe:
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.Cooper and Liston (1979) carried out a genetic analysis o f the data o f  
Chesley, and combined their own data with that o f Adams and Finlay son 
(both had been collected from Aberdeen Maternity Hospital and used 
Nelson's definition o f pre-eclampsia). The combined data showed that the 
incidence o f severe pre-eclampsia in sisters of severely pre-eclamptic index 
cases was 15.9% and the incidence in mothers was 22.8%.
Sutherland et al (1981) compared the incidence o f pre-eclampsia in the 
mothers and mothers-in-law o f pre-eclamptic women and normotensive 
controls. They found that the incidence in mothers o f controls and mothers- 
in-law o f pre-eclamptic women were similar 3% and 4%. Whereas the 
incidence in mothers o f pre-eclamptic women was higher namely 14%.
:T
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A study carried out in Iceland (Arngrimsson et al, 1990) investigated three 
and four generations o f families o f women with either eclampsia or pre­
eclampsia. Comparing the incidence o f pre-eclampsia and eclampsia in 
daughters and daughters-in-law o f index cases they found similar increased II
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incidence as previous studies, 23% in daughters o f index cases compared to 
10% in daughters-in-law. They also found a higher incidence in grand 
daughters compared to grand daughters-in-law but this difference was not 
significant.
By comparing the occurrence o f disease in relatives o f affected women with 
expected incidence in a postulated genetic model it is possible to develop a 
hypothesis for the genetic basis for pre-eclampsia and eclampsia. Cooper et 
al (1993) have overviewed data from the reports described above and have 
summarised the evidence for two possible genetic models, consistent with 
the pedigree studies. The simple recessive model with the genes acting in 
the mother fits with the data o f Chesley et al (1986), Cooper and Liston 
(1979), Sutherland et al (1981) and Adams and Finlayson (1961).
The Icelandic data (Arngrimsson et al, 1990) fits either the simple recessive 
model or a dominant gene model with 50% penetrance again acting in the 
mother. Small studies carried out on the incidence o f pre-eclampsia in twin 
pairs (Thornton and Onwude, 1991) have demonstrated discordance which 
would appear to be incompatible with the simple recessive model. A  study 
by Cooper et al (1988) found an increased prevalence o f eclampsia in 
daughters born of an eclamptic pregnancy compared to a non eclamptic 
pregnancy which they suggest indicates an influence o f the fetal genotype in 
susceptibility to eclampsia.
That studies have consistently found a reduced incidence o f pre-eclampsia 
and eclampsia in relations by marriage argues against the maternal-fetal 
genotype by genotype interaction. This is not conclusive however, as a 
condition which is heritable, but only manifest in pregnancy, may not, by its
 : .......
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occurrence in both mother and daughter show in which generation genes 
responsible are acting.
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The conclusions of Cooper et al (1988) are supported by studies which 
have suggested a major histocompatability complex in the genetic 
mechanism o f PIH and pre-eclampsia (Redman et al, 1978; Kilpatrick, 
1987; Kilpatrick et al, 1987). The data o f Kilpatrick et al (1987) shows 
that an increased incidence o f HLA DR4 has been found in pre-eclamptic 
women and their babies. In a further study (Kilpatrick et al, 1989), the 
frequency o f HLA DR4 was increased in pre-eclamptic sisters o f pre­
eclamptic women, compared to pre-eclamptic sisters o f normotensive 
women. The association with HLA DR4 suggests a possible abnormal 
immune response related to HLA DR4 gene or a genetic link between HLA 
DR4 and the presumed gene for susceptibility to pre-eclampsia and 
eclampsia.
Ward et al (1993) found a significant association between pre-eclampsia 
and the angiotensinogen gene which has been localised to chromosome Iq. 
The results o f this study were supported by Arngrimsson et al (1993) who 
also suggest that molecular variation in the angiotensinogen gene, or a 
closely linked gene on chromosome Iq may predispose to pre-eclampsia.
Until the causative gene or genes are conclusively identified at the 
molecular level the genetic basis o f PIH cannot be certain, and based on 
family pedigree studies, there is as yet no consensus on the probable genetic 
model responsible for its occurrence. However it appears clear that there is 
an inherited component in susceptibility to PIH and pre-eclampsia. Data 
from the studies reviewed while reporting differing incidence o f disease 
amongst family members agree that the incidence o f pre-eclampsia and
_______  -
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eclampsia is higher in the mothers, daughters, sisters and granddaughters o f  
index women than in either mothers or daughters-in-law, or in the families 
of normotensive women. Use o f this information in a clinical setting may 
identify a group o f women who are at an increased risk o f developing PIH 
and pre-eclampsia.
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Chapter Two
Research Method
41 I
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2.1 Study design
This study used a prospective cohort design. f
2,2 Setting
The study was carried out within the Glasgow Royal Maternity Hospital. This 
teaching hospital primarily serves the north and east o f Glasgow although 
women from all areas o f Glasgow attend the hospital. Approximately 4000
carried out.
women were delivered each year during the period in which this research was
2.3 Time frame
The initial time frame for this study was a period o f 26 months. 14 months was 
designated as the recruitment period, a fiirther six months was required for the 
last women recruited to complete their pregnancies, The final six months was 
required for case record data extraction. A  further six months extension to the 
study was required for data analysis.
2.4 Funding
The study was fiinded for a period o f two years by the Chest Heart and Stroke 
Association o f Scotland.
2.5 Sample size
The calculation for sample size, Table 2.1, is based on the following 
assumptions, as from the literature reviewed in chapter one (MacGillivray,
1958; Cooper and Liston, 1979; Chesley et al, 1962).
.
I
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Table 2.1. Power calculation o f comparison o f assumed outcome o f pregnancy 
between the positive and negative family history groups.
will develop PIH will not develop 
PIH
positive family 
history o f  
pregnancy 
hypertension
75 225 300
negative family 
history o f  
pregnancy 
hypertension
75 625 700
150 850 1000
Odds ratio = 2.778 ( 1.949 - 3.960 95% confidence interval )
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The incidence o f PIH within the general population is approximately 15%. The 
expected family history o f  PIH will be 30%. The incidence o f  pre-eclampsia in 
daughters whose mother had pre-eclampsia is approximately 25% and 
therefore approximately 25% o f women who have a positive family history will 
develop the condition.
Based on these assumptions, a sample size of 1000 primigravid women will 
show an odds ratio o f more than two for the development o f mild or severe 
PIH, in those with a family history o f hypertension in pregnancy, compared to 
those with no such family history ( 80% power, 95% confidence limit.). In 
order to compensate for an assumed non response rate o f approximately 15%, 
an additional 15% was added to the calculated required sample size. A sample 
of 1150 women was therefore required for the study.
2.6 Development of Research Tools
2.6.1 Aim
The aim in developing the research tool was to develop a method o f collecting 
information, as reported by the women themselves, on family history o f  
hypertension in pregnancy and cardiovascular disease.
2.6.2 Smwey design
A survey design was chosen as the appropriate method o f obtaining 
information on the prevalence, distribution and interrelationship o f variables, 
namely, family history o f pregnancy hypertension and cardiovascular disease 
within the study sample (Seaman, 1987).
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Self report suiveys may take the form of personal interviews or written 
questionnaires. Both methods may be used for obtaining information on 
respondents such as their attitudes, beliefs and social behaviour as well as more 
specific information such as that on health or employment. Using a personal 
inteiview, the researcher will meet each subject and will ask a previously 
developed set o f questions. This method allows the interviewer to re-word 
questions not initially understood, and to probe for more detailed responses 
where necessaiy, thereby providing detailed information o f a high quality. The 
disadvantage o f this method is that it requires a lot o f time both from the 
interviewer and the respondent and is therefore costly and impractical to apply 
to a large study sample.
Questionnaires are self administered, the respondent reading the question and 
giving a written response. The information gained from a questionnaire will 
usually be more superficial than that obtained from an interview however, they 
have the advantage o f being simple and inexpensive to administer to a large 
study population. In using a questionnaire, the researcher assumes a certain 
level o f literacy on the part o f the respondent and the questionnaire must be 
carefully developed in order to be understood by the respondents in the 
absence o f the researcher.
In this study, the survey was to be applied to a large study population, as a 
screening test, the requirements o f which are discussed in chapter one (Mohide 
and Grant, 1989). A postal questionnaire was chosen as the most appropriate 
research tool for this study. This was economical to apply to the study 
population and allowed the women to find out information from family 
members before responding to questions.
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2.6.3 Questioniiaire design
A questionnaire comprises three parts; the covering letter, instructions and the 
questions (Seaman, 1987).
i) The covering letter explains to the recipient, who is carrying out the 
research, its purpose and importance. It should give assurance o f 
confidentiality in handling and reporting of information received.
ii) The instructions should be simple and understandable, they explain how 
responses should be made and how the questionnaire is to be returned.
iii) Two forms o f questions may be used in questionnaires, open ended 
questions allow the respondents to answer in their own words while closed- 
ended, standardised or structured questions provide a fixed set o f responses 
from which the subject must choose the most appropriate response.
Closed ended questionnaires may vary in complexity from the most simple; 
Yes, No Don't know responses to scaled responses such as the Likert-scale 
(Likert, 1935) where each question is in the form o f a statement either 
negatively or positively worded and has a five point response scale from 
strongly agree to strongly disagree tor each question.
Open ended questions may provide the opportunity for an individual response 
to questions however, these may be difficult to categorise and, as subjects are 
frequently unwilling to write a detailed response questionnaires, may be 
incompletely filled in. Closed-ended questionnaires may be less threatening to 
subjects, they may be quickly completed and, more reliably interpreted due to 
the standardised responses. The disadvantage of closed ended questionnaires 
is that they oblige respondents to choose one of the predetermined responses 
and so may be insufficiently specific ( Polit and Hungler, 1985).
_________________________________________________________
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In developing the questionnaire the researcher must decide what data is 
required, information which would be desirable must be weighed up with what 
may be practical to collect. Questions should be clear, simple, unambiguous 
and avoid jargon or complex terminology (Burns & Grove, 1987).
2.6.4 Developing the qtiestionnaire
Individual interviews were carried out with 10 primigravid women attending 
the ante-natal booking clinic. The women were given an explanation o f the 
study and asked to participate, all gave consent. They were then asked about 
their own history o f hypertension as well as their knowledge o f  their family 
history o f hypertension in pregnancy and cardiovascular disease. A detailed 
record o f the family history was completed during the interview by the 
researcher.
Eight women had knowledge o f the histories o f their immediate families, that 
is, mother, fathers, sisters and brothers; six reported that they would be able to 
find out about the history o f grandparents, aunts and uncles. Two reported 
that they would be able to obtain some, though not all o f  this information. 
Two women had knowledge only o f cardiovascular disease in their immediate 
family but reported that they would be willing to enquire about history o f  
hypertension in pregnancy.
Results o f  these interviews suggested that women knew, or would be willing 
and able to find out, information about their own family history o f pregnancy 
hypertension and cardiovascular disease.
A  questionnaire was compiled based on these interviews. ( Appendix 1) The 
aim o f this questionnaire was that it would allow the researcher to develop a
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detailed family tree for each o f the respondents. The questionnaire comprised 
instructions for completion and a set o f open ended questions about family 
history o f pregnancy hypertension and cardiovascular disease in relation to the 
following family members; siblings, parents, maternal aunts and uncles and 
maternal grandparents. Women were asked to give dates o f  birth o f  family 
members in order to determine birth order o f pregnancies affected by 
hypertension. A covering letter explaining the nature and purpose o f the study 
and assuring respondents o f the confidentiality o f their responses was included.
2.6.5 Pilot study o f questionnaire
A consecutive sample o f 10 primigravid women attending the ante natal 
booking clinic were given an explanation o f the study and asked to participate. 
The women were asked to take the questionnaire and to find out as much as 
possible about their family history before completing and returning the 
questionnaire. A stamped addressed envelope was provided.
The results o f this study were poor, nine women initially agreed to participate, 
however, only four questionnaires were returned, three o f which were 
incomplete. This indicated that women were not willing, or were unable to 
complete such a large and detailed family history questionnaire.
2 .6.6 Developing the second questionnaire
Following the pilot study a second questionnaire was developed (Appendix 2). 
The aim in developing this questionnaire was that it would provide only the 
essential information on family history o f pregnancy hypertension and 
cardiovascular disease and would be easily understood and completed by the 
sample o f women required for this study. Two essential features were
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identified. Firstly, the questionnaire would be short, no more than one side o f  
an A4 sheet. Secondly, questions would be simple to understand and to 
answer. In order to meet these requirements questions were restricted to 
history o f hypertension in the woman herself and in the pregnancies o f close 
family members i.e. mother, sisters, aunts, and grandmothers. A set o f  
questions were included about family history o f cardiovascular disease in close 
family members these were specified as siblings, parents aunts and uncles and 
grandparents. Cardiovascular disease was identified as 'stroke', 'heart disease' 
and 'high blood pressure'.
A set o f 11 questions were developed. Wording o f the questions was based on 
the initial interviews with women in the hospital ante natal clinic. Terms 
identified as being commonly used and understood by most women, for 
example, 'high blood pressure' and 'stroke', were used. Each question was 
closed-ended and had the same pre-determined set o f responses, these were; 
Yes, No and Don't Know (Burns & Grove, 1987)
2 .6.7 Pilot stndy o f second questionnaire.
A consecutive sample o f ten primigravid women attending the ante natal 
booking clinic were given an explanation o f the study and asked to complete 
the questionnaire, while waiting at the clinic but without assistance from the 
researcher. They were then individually interviewed and the responses 
discussed. All the women agreed to participate in the study. All reported that 
they found that the questionnaire simple to understand and to complete. 
Discussion with the women confirmed that the responses to the questionnaire 
gave a true reflection o f the women's knowledge o f their family history o f  
hypertension.
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Based on these interviews a covering letter was developed explaining the 
purpose o f the research study. In explaining why the woman had been asked 
to participate in the study the letter stressed the value o f  each woman's 
response in increasing our understanding o f hypertension in pregnancy. The 
letter outlined the nature o f the questionnaire and explained simply which 
family members should be included in responses The letter explained that 
responses returned would be treated confidentially. A contact telephone 
number for the researcher was included for women who wished to obtain 
further information about the study. Simple instructions for completion o f the 
questionnaire were included on the questionnaire itself.
The results o f the pilot study suggested that the questionnaire would appear to 
identify women with both positive and negative history o f hypertension in 
pregnancy and cardiovascular disease based on information given by the 
woman herself. Its simple closed-ended construction makes it acceptable to 
the study population and thus potentially suitable for use as a screening test. 
The disadvantage o f this questionnaire is that it is not specific. In relation to 
pregnancy hypertension, the questionnaire may identify that a woman has a 
sister who had hypertension in pregnancy, but would not identify how many 
sisters she had or how many were affected. Similarly, affected aunts and 
grandmothers may have been either maternal or paternal. In relation to 
cardiovascular disease it might be identified that a member o f  the family had 
heart disease but not who was affected nor how many family members were 
affected. However this is a pragmatic study which aims to demonstrate 
whether information readily available from women attending an ante natal 
clinic will be o f value in predicting those at risk o f developing PIH. The
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questionnaire gives sufficient information to identify women with positive and 
negative family histories o f pregnancy hypertension and cardiovascular disease.
2.7 Study entry
The study aimed to recruit a consecutive sample o f women booking for 
maternity care at the ante natal clinic at Glasgow Royal Maternity Hospital.
2 .7.1 Criteria
Eligibility for the study was based on the following criteria;
i) Primigravid
As a diagnosis o f pre eclampsia in multiparous women is not reliable only 
primigravid women were included in this study.
ii) Booking within the first trimester o f pregnancy
As discussed in chapter one, recording the blood pressure in the first trimester 
o f pregnancy, prior to the physiological drop in blood pressure which occurs in 
the second trimester, gives an accurate base line, on which a later rise in blood 
pressure may be compared. A  woman with essential hypertension, whose 
blood pressure is recorded for the first time in the second trimester may appear 
to have normal blood pressure. When her blood pressure rises in the third 
trimester, to her normal level, a mistaken diagnosis o f PIH or pre-eclampsia 
may be made. (MacGillivray et al, 1969; Friedman and Neff, 1976; Chesley, 
1978) For this reason women who attended the ante natal clinic for the first 
time after the first trimester were excluded from the study.
___________
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iii) Ethnic background.
Only women from northern European Caucasian background were included in 
the study. This excludes variations in blood pressure distributions found in 
people o f different racial groups (Turnbridge and Donnai, 1983).
2.7.2 Method o f recruitment
There were three stages in recruitment to the study;
i) Review o f case records
Case records o f all women booking at the ante natal clinic were reviewed, 
potentially eligible cases were identified. A study questionnaire, introductory 
letter and stamped addressed envelope were placed in the case record.
ii) Exclusion
Women booking at the ante natal clinic had their case history taken by the 
clinic midwife. Those women who did not meet the study entry criteria, as 
described above, were excluded from the study.
iii) Consent gaining
The clinic midwife gave each eligible women an explanation o f the nature and 
purpose o f the study and asked if she would be willing to participate and give 
permission for information for the study to be abstracted from her case records 
following delivery. Women consenting to join the study were given the 
questionnaire, covering letter and stamped addressed envelope. They were 
asked to find out as much as possible about their family history before 
returning the questionnaire.
___________________ _
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2.7.3 Documentation
An index card was prepared for each woman following study entry. This card 
contained the name, address, hospital unit number and date o f study entry for 
each woman. The date o f questionnaire return was entered on the card, this 
record allowed the identification o f women whose questionnaires had not been 
returned prior to sending questionnaire reminders.
2 .7.4 Questionnaire reminder
A letter o f reminder including a second questionnaire and stamped addressed 
envelope was sent to all women who had not returned their questionnaire 
within one month. Prior to reminders being sent case records were reviewed 
to confirm the woman's address and to exclude women who had miscarried 
subsequent to study entry. Women who did not respond to the second 
questionnaire were considered non-respondents and were not further followed 
up.
2.8 Study measures of outcome
The first measure o f outcome in this study was the woman's family history o f  
hypertension in pregnancy and cardiovascular disease, as reported by the 
woman herself The method o f data collection for this was self report 
questionnaire. The second measure o f outcome for the study was the outcome 
o f pregnancy of the women within the study group. The method o f data 
collection for this was retrospective case record review. A data collection 
form (Appendix 3) was completed for each woman at the end o f pregnancy, 
recording the following information:
i) Identifying information; name and case record number.
___________
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ii) Demographic details; postcode, age. This information gives a brief 
description o f the sample. Use o f the postcode designated deprivation 
category (Carstairs and Morris, 1991) allows the study group to be compared 
with the general population within the catchment area o f Glasgow Royal 
Maternity Hospital.
iii) Baseline recordings; gestation and blood pressure at booking. This 
information is required in order to make an accurate retrospective diagnosis o f  
development o f PIH (mild, moderate or severe) and essential hypertension 
(MacGillivray et al, 1969; Friedman and Neff, 1976; Chesley, 1978).
iv) Pregnancy outcome; gestation at delivery, birthweight, mode o f delivery 
and requirement for admission to special care baby unit. This information was 
used to compare study groups.
v) Pregnancy complications; diagnosis o f PIH or essential hypertension if 
recorded in the case record, highest recorded blood pressure, degree o f  
proteinuria and blood test results. In addition any daycare attendance or 
admissions for PIH were recorded as well as any antihypertensive therapy 
required.
Development o f PIH formed the main study outcome for comparison o f  
women identified by the questionnaire as having a either a negative or positive 
family history o f pregnancy hypertension or cardiovascular disease. Further 
information on pregnancy outcome was collected for women who developed 
hypertension. This formed part o f an audit within Glasgow Royal Maternity
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Hospital on the outcome o f all pregnancies o f women who developed 
hypertension, and is not reported in this study.
2.8. i  Questionnaire non respondents
The family histoiy o f women who did not return their questionnaire is
unknown however these women did give consent to study entry and data
extraction from case records. Therefore this group may be compared with the 
■mam group tor pregnancy outcome.
I
Î
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2.9 Analysis
All data were entered on database dBase IV (Borland international, inc. 
California), and analysed using SPSS (SPSS inc. Chicago). Data were analysed
for the overall incidence o f PIH, and the incidence in groups o f women who 
reported either a positive or negative family history o f hypertension in
i
:
pregnancy or cardiovascular disease. Data were analysed using 2 x 2  
contingency tables which gave incidence, sensitivity and specificity as well as 
positive and negative predictive values and odds ratio for the development of 
PIH in positive and negative family histoiy groups.
Sensitivity is defined as an index o f a test's ability to detect the condition when 
it is present. Specificity is defined as a test's ability to correctly exclude a 
condition when it is absent. The positive predictive value refers to the
proportion o f women who have a positive test and who actually have the
. . . . .  condition. The negative predictive value refers to the proportion who have a
.negative test and do not develop the condition. The odds ratio is the ratio o f
women who have a particular test result among those who have the condition,
55
to individuals who have the same test results but do not have the condition 
(Mohide and Grant, 1989). Statistical significance between groups was 
analysed using Pearson Chi square test.
2.10 Definition of terms.
2.10.1 Dami/y history
Studies reviewed in chapter one define family history as being o f three 
generations, grandmother, mother, aunts, daughters and sisters (Chesley et al, 
1968; Cooper et al, 1988). Mothers-in-law and sisters-in-law have not been 
included in this study as the incidence o f pre-eclampsia in these relatives o f  
women with pre-eclampsia is low (Cooper and Liston, 1979; Sutherland et al, 
1981; Chesley and Cooper, 1986).
Male relatives; father, uncles and brothers were included as this study 
investigates the possible link between family history o f cardiovascular disease 
and the development o f PIH (Adams and Finlayson, 1961). For this study, 
family history is defined as relating to parents siblings, aunts, uncles and 
grandparents o f the study members.
3.10.2 Pregnancy Hypertension and Cardiovascular disease
The purpose o f the study was to evaluate information on family history as 
reported by the women themselves therefore, no attempt was made to verify 
information by tracing the medical records of family members. Pregnancy 
hypertension for this study is defined as, hypertension occurring in the 
pregnancy o f a family
IIi
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member, as reported by the woman herself. Cardiovascular disease is defined 
as hypertension not confined to pregnancy (referred to as high blood pressure) 
cardiac disease (described as heart disease) or cerebro-vascular accident 
(referred to as stroke).
2.10.3 Pregnancy-induced hypertension.
PIH occurs in a woman who is normotensive prior to pregnancy and 
throughout the first 20 weeks of pregnancy, who then develops hypertension. 
The condition may be defined as mild, moderate or severe. Hypertension is 
defined as a diastolic blood pressure of 90mmHg or greater on two 
consecutive occasions at least four hours apart. In the absence of proteinuria 
this is classified as mild or moderate PIH. Moderate PIH was diagnosed where 
the systolic blood pressure was greater than MOmmHg or the diastolic blood 
pressure greater than 90mmHg on two occasions before 28 weeks gestation, or 
greater than 150mmHg systolic or greater than 95mmHg diastolic between 28 
and 36 weeks gestation (Collins and Wallenburg, 1986). The presence of 
significant proteinuria, that is proteinuria greater than 300 mg in 24 hour urine 
collection, or greater than two pluses on Multistix-S.G (Ames) urine test, or a 
diastolic blood pressure persistently greater than llOmmHg was required for 
the disorder to be classed as severe PIH (Davey and MacGillivray, 1986).
2.10.4 Eclampsia
Eclampsia is characterised by grand mal seizures, in the second half of 
pregnancy, not attributable to epilepsy or to any convulsive problem. 
Eclampsia is usually associated with hypertension but may occur in women 
where no hypertension has been identified (Greer, 1992).
"  ' ' ______________________________
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of antihypertensive treatment.
In order to obtain the most accurate classification all of the above definitions
:2.10.5 Essential Hypertension
,.,'V
Essential or chronic hypertension is defined as hypertension, that is, a diastolic 
blood pressure of 90mmHg or more, which pre-dates pregnancy, occurs prior 
to the 20th week of pregnancy or persists after the pregnancy is completed 
(Walker, 1991). As described in chapter one this condition may easily be 
confused with PIH where a pregnant woman does not have her blood pressure 
recorded in the first trimester of pregnancy. A woman with previously 
observed essential hypertension may develop superimposed PIH diagnosed 
where there is exacerbation of hypertension the development of proteinuria and 
a rising plasma urate level.
i2.10.6 Antihypertensive treatment 
For this study a woman was classified as having had treatment where she was 
prescribed regular antihypertensive therapy (discussed in chapter one), as 
recorded in the case record. This did not include women prescribed one dose
Î
I
were applied by the researcher on retrospective case record review.
II
I
I
C H A P T E R  T H R E E
R E S U L T S
______________________
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3.1 Sample Description
3. L I Study entry
A total of 1287 consecutive women were initially identified as being potentially 
eligible for study entry after screening of case records prior to the antenatal 
booking visit. Twenty eight (2.1%) women failed to attend for their hospital 
booking appointment. A further 46 (3.5%) women were excluded from the study 
for clinical reasons namely; 15 who were identified by ultrasound scan as having a 
non continuing pregnancy, one ectopic pregnancy and 30 women who, following 
history taking and ultrasound scan were found to be over 12 weeks gestation and 
therefore were not eligible for the study. Following the exclusion procedure 1213 
women were eligible to join the study. Thirty two women did not agree to 
participate and 1181 were initially entered into the study (97.3% consent).
3.1.2 Area of residence, deprivation category
Table 3.1 compares deprivation categories by area of residence between women 
entered into the study and the general population within the catchment area of the 
Glasgow Royal Maternity Hospital. There was no statistically significant 
difference between the groups for any of the deprivation categories. This suggests 
that the study sample was representative of the general population of women who 
attend the Glasgow Royal Maternity Hospital.
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Table 3.1 Deprivation categories, by area of residence, of women in the study 
(n=l 181) compared to the population (pop) within the catchment area of the 
Glasgow Roy^ Maternity Hospital (GRMH)
Deprivation Category 
(by postcode)
Number 
Study pop
% GRMHarea
pop
% difference
between
groups
1-3 242 20.4 282,697 28.6 ns*
4-5 306 25.9 215,382 21.8 ns
6-7 610 51.6 488,925 49,5 ns
Not available 23 1.9 214 0.02 ns
Total 1181 99.8 987,218 99.9 ns
* difference between groups is not significantly (ns) different
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3.1.3 Reminders
There were 503 women who did not initially return the questionnaire. Case 
records of these women were reviewed four weeks after study entry, prior to 
sending the questionnaire reminder. Twenty six women had miscarried between 
12 and 16 weeks and 11 had moved from the area or transferred to another 
hospital for antenatal care. These women were not sent questionnaire reminders 
and were excluded from the main analysis. After questionnaire reminders had 
been sent to the remaining 466 women 1042 questionnaires were ultimately 
returned (91% response). Data on pregnancy outcome was collected for women 
who did not return the questionnaire and is discussed in chapter 3.3.9.
3.1.4 Data collection
Review of the returned questionnaires revealed that 28 questionnaires contained 
insufficient information for analyses, including two women who wrote explaining 
that as they had been adopted they had no knowledge of their family history. The 
remaining 1014 questionnaires were complete. Retrospective case record review 
was the method of data collection for pregnancy outcome. Following case record 
review data was incomplete in 26 cases. These included; missing case records 
(n=10), case records containing missing information sufficient to require exclusion 
of the women from the study (n=2) and women who had transferred care or 
moved outwith the area prior to delivery (n=14). This left 988 cases where there 
was complete data for both questionnaire and pregnancy outcome.
S. 1.5 Identification of high risk factors
The aim of this study was to investigate the risk conferred by a family history of 
hypertension (identified by self report) on apparently normal pregnant women, 
therefore women who had identifiable high risk factors for development of PIH 
either from their past history, or at the outset of pregnancy were excluded from 
the main analysis of data on family history, although data on pregnancy outcome is
;W
presented for these women. Thirteen women who had twin pregnancies within 
the initial study group were excluded because of the increased incidence of PIH in 
twin pregnancies (MacGillivray, 1958). As PIH occurs exclusively in the second 
half of pregnancy women who miscarry will not be tested for their potential of 
developing PIH therefore 20 women who had returned completed questionnaires 
but who had subsequently miscarried were also excluded from further analyses. 
Exclusion of these groups left data for 955 singleton pregnancies. Sixty five 
women had essential hypertension, either diagnosed for the first time in early 
pregnancy or identified by past history. Pre-existing hypertension is a known risk 
factor for the development of superimposed PIH and therefore data for family 
history of these women was analysed separately from the main group, although 
data for pregnancy outcome is presented alongside that of the main study group. 
Thus the total of singleton pregnancies which had progressed to at least 24 weeks 
gestation, in women who were normotensive at outset of pregnancy was 890, this 
group formed the main study sample.
3.1.6 Maternal age
The mean age of women in the study group was 25 years (SD 4.5)
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3.2 Results of the family history questionnaire
3.2.1 Personal history
In relation to personal history of hypertension 62 women reported that they had a 
history of high blood pressure, either currently or in episodes in their past history. 
Retrospective case record review confirmed that each of these women had a 
documented medical history of hypertension. As described above, data on these 
women and an additional three women, who were first identified as having 
essential hypertension during the first half of pregnancy, are analysed separately 
from data for the main sample.
Eighty-seven women reported a history of renal problems. Retrospective review 
of case records of these women revealed in each case that the women's history 
was confined to episodes of either cystitis or urinary tract infection. These 
women had no hypertension at booking and had no evidence of renal impairment 
and were therefore included within the main analyses, although they were also 
identified within the study group for identification of risk of PIH.
3.2.2 Family history of hypertension in pregnancy
Within the main study sample of 890 women 318 women gave a history of 
someone in their family with pregnancy hypertension (table 3.2), 561 had no 
family history of pregnancy hypertension and 11 women did not know their family 
history. The incidence of pregnancy hypertension in the family histoiy of the 
study group was therefore 35.7%. This question identified our first potential high 
and low risk groups (318 with positive family history (high risk) / 561 with no 
family history of pregnancy hypertension (low risk) ).
One hundred and eighty-four women reported that their mothers had hypertension 
while pregnant, 58 did not know whether their mothers had been affected and the
64
remaining women (n=648) reported that their mothers had not had hypertension in 
pregnancy. In relation to sisters and aunts, women were first asked if they had a 
sister or aunt who had been pregnant, then whether they had been aflfected by 
hypertension in pregnancy. Under half the respondents (n=377) had a sister who 
had been pregnant, of these 84 reported that they had a sister with an affected 
pregnancy. Most women had an aunt who had been pregnant (n=762) and of 
these 113 reported that they had an aunt who had an affected pregnancy. Seventy 
women reported that they had a grandmother who had a pregnancy affected by 
hypertension. As would be expected, in giving information on family history of 
pregnancy hypertension women had most information on closer relatives. Only 
ten women who had a sister who had been pregnant did not know if a pregnancy 
had been affected by hypertension, although seven women did not know if they 
had a sister who had been pregnant. Fifty eight women did not know if their 
mothers pregnancies had been affected. However in relation to aunts and 
grandmothers more women were unable to give information. Of the women who 
had an aunt who had been pregnant 168 did not know whether they had a 
pregnancy affected by hypertension and 253 women were unable to give 
information about their grandmothers pregnancies.
Some women had several family members affected by hypertension in pregnancy, 
32 women reported that both their mother and a sister had hypertension in 
pregnancy. Forty-seven women had both mother and an aunt affected. In 18 
cases the woman's mother, aunt and grandmother were reported to have had 
hypertension in pregnancy, one woman reported that three generations of her 
family (mother, sister, aunt and grandmother) had been affected.
3.2,3 Family history of cardiovascular disease
All respondents were able to give information about their family's history of 
cardiovascular disease. 437 women reported a positive family history and 453
reported that they had no family history of cardiovascular disease. The incidence 
of cardiovascular disease in the family histoiy of the study group was therefore 
49.1%. In considering specific types of cardiovascular disease (table 3.3) 346 
women reported that they had a family history of essential hypertension, 283 of 
cardiac disease and 192 of stroke although these groups are not exclusive and 
women may have reported more than one type of cardiovascular disease in her 
family history.
3,2.4 Negative andDonH know responses
The questionnaire was completed by 351 women who gave completely negative 
responses, that is, they reported that they had no family history of cardiovascular 
disease or of hypertension in pregnancy. These women formed our presumed 
lowest risk group for the development of pregnancy induced hypertension. With 
the exception of the two women who had been adopted all respondents were able 
to give at least information about history of cardiovascular disease in their family.
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Table 3.2 Results of family history questionnaire (excluding women with essential
hypertension and twin pregnancies.) n-890
YES (%) NO (%) Don't know
Family history of cardiovascular disease 437 (49.1) 453 (50.8) 0
Family history of pregnancy hypertension 318 (35.7) 561 (63.0) 11 (1.2)
Mother had pregnancy hypertension 184 (20.6) 648 (72.8) 58 (6.5)
Sister(s) who have been pregnant 377 (42.3) 506 (56.8) 7 (0.78)
Sister(s) had pregnancy hypertension 84 (22.2)* 283 (75.0) 10 (2.6)
Aunt(s) who have been pregnant 762 (85.6) 119 (13.3) 9 (1.0)
Aunt(s) had pregnancy hypertension 113 (14.8)** 481 (63.1) 168 (22.0)
Grandmother(s) had pregnancy 70 (7.8) 567 (64) 253 (28)
hypertension
* % of sisters who have been pregnant 
** % of aunts who have been pregnant
Table 3.3 Self reported family history of cardiovascular disease
number %
All cardiovascular disease 437 49.1
Essentiai hypertension 346 38.8
Cardiac disease 283 31.7
Stroke 192 21.5
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3.3 Pregnancy Outcome
3.3.1 Incidence o f hypertension
Within the initial study population of 955 complete cases of singleton pregnancies 
where pregnancy reached at least 20 weeks, 134 (14.0%) women subsequently 
developed PIH (table 3.4). Sixty five women had essential hypertension (6.8%), 
of these women 27 (41.5%) developed superimposed PIH. The remaining 756 
(79.1%) women had no history of hypertension and were normotensive 
throughout their pregnancy.
Within the sample of women who had singleton pregnancies and excluding women 
with essential hypertension the incidence of PIH was 15.06%.
Of the 134 women who had PIH, 101 (11.3% of the total sample) were mildly 
affected, 20 (2.2% of the total sample) had moderate disease and 13 (1.4% of the 
total sample) developed severe PIH, 42 women (4.7% of the total sample) in this 
group received antihypertensive therapy, table 3.5.
3.3.2 Gestation at birth
Table 3.6 summarises the obstetric outcome for women within the three groups 
(normotensive, PIH and essential hypertension). The mean gestation at delivery 
was 39 completed weeks for both the normal and PIH groups (SD 3 and 2 
respectively). For the essential hypertension group the mean gestation of delivery 
was 38 weeks (SD 5). The difference in gestation at delivery between the groups 
was not significant.
i
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Table 3.4 Incidence of hypertension in singleton pregnancies 
n=955
Diagnosis % number
Normotensive 79.1 756
PIH (includes mild, moderate and severe) 14.0 134
Essential hypertension 6.8 65
Total 99.9 955
Table 3.5 Severity of PIH in singleton pregnancies excluding women with
essential hypertension
n=134
Degree of PIH % (of total sample) number
Mild 11.3 101
Moderate 2.2 20
Severe 1.4 13
Antihypertensive therapy 4.7 42
x__
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Table 3,6 Obstetric outcome for singleton pregnancies by hypertension group 
(n=955)
Obstetric outcome normotensive
n=756
pm
n=134
essential
hypertension
n=65
Intrauterine death 4 (0.5%) 0 0
Perinatal death 0 2(1.4% ) 1 (1.5%)
Mean (SD) gestation at 3 9 (3 ) 3 9 (2 ) 3 8 (5 )
delivery, in weeks
Preterm delivery 79 (10.4%) 16(11.9%) 5 (7.6%)
(<37 weeks)
Birthweight mean (SD) 3.26kg (0.59) 3.29 (0.62) 3.13 (0.64)
Small for gestational age 72 (9.5%) 11 (8.2%) 3 (4.6%)
(<10th percentile)
Admission to SCBU 73 (9.6%) 21 (15.6%)* 7 (10.7%)
*%% = 4.36; p< 0.05
v>\-;:.l-:.r ------- ------
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The prevalence of preterm delivery, that is delivery prior to 37 weeks gestation,
for the whole sample was 10%.
In the normal group 79 (10.4%) women delivered prematurely, there were 16 
(11.9%) preterm deliveries in the PIH group and five (7.6%) in the essential 
hypertension group. There was no statistically significant difference in the number 
o f  preterm deliveries between the groups.
3.3.3 Birth weight
Mean birth weight was 3.26kg (SD 0.59) in the normal group, 3.29kg (SD 0.62) 
in the PIH group and 3.13kg (SD 0.64) in the essential hypertension group. The 
difference in birth weight between the groups was not statistically significant. The 
incidence o f babies who were small for gestational age, defined as birth weight 
below the 10th percentile for gestation (Normogram for boys/girls. Medical 
Research Council, 1979, Edinburgh) was 9% for the group as a whole, 9.5% 
(n=72) in the normal group, and 8.2% (n = ll)  in the PIH group. There was no 
statistically significant difference between these two groups. There were only 
three babies (4.6%) who were small for gestational age in the essential 
hypertension group, this was not significantly less than the other two groups.
3.3.4 Admission to Special Care Baby Unit
Within the normal group 73 babies (9.6%) were admitted to the special care baby 
unit (SCBU). There were seven (10.7%) babies admitted in the essential 
hypertension group. However 21 babies (15.6%) were admitted in the PIH group 
and this is a significantly higher number.
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3.3.J Fetal and perinatal loss
In the normal group there were four intrauterine deaths, one o f  these occurred at 
26 weeks and was associated with fetal abnormality, another occurred at 25 
weeks following premature rupture o f  membranes, the remaining two deaths 
occurred at 26 and 27 weeks and were o f unknown cause. In the PIH group there 
were two perinatal deaths, one o f these occurred in a baby delivered at 30 weeks 
gestation due to severe PIH. This baby died following intraventricular 
haemorrhage at four days old. The second death occurred in the baby o f a woman 
with mild PIH. The baby was delivered at term and died at one day old, death 
was due to birth asphyxia. In the essential hypertension group there was one 
perinatal death. This baby died at six days old due to respiratory distress 
syndrome after delivery at 29 weeks gestation due to severe superimposed PIH in 
the mother.
3.3.6 Mode of delivery
Within the normal group 105 women (13.8%) were delivered by caesarean 
section, 165 (21.8%) had instrumental delivery, either forceps or ventouse and the 
remainder had spontaneous delivery. In the PIH group 20 women (14.9%) were 
delivered by caesarean section, 34 (25.3%) had an instrumental delivery. Within 
the essential hypertension group nine women (13.8%) were delivered by caesarean 
section and 13 (20%) had instrumental delivery. There was no statistically 
significant difference between these groups for mode o f delivery.
3.3.7 Pregnancy outcome in women with severe PIH
Within the group o f 134 women who had PIH there were 13 women who had 
severe disease. Although this is a small group, morbidity would be expected to be 
higher in these women and their pregnancy outcome is described in more detail. 
Within this group there were eight preterm deliveries (61.5%), compared to 
11.9% in the PIH group as a whole. Three babies in the severe group were small
 :  _
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for gestational age (23%), two where the birth weight was below the 5th 
percentile for gestation. Seven babies (53.8%) were admitted to the special care 
baby unit and as described above there was one perinatal death. These outcomes 
confirm that development o f severe PIH carries considerable risk to the fetus.
3.3.8 Pregnancy ont come for twin pregnancies
Thirteen women had twin pregnancies and were excluded from the analysis of 
family history data. In this group two women (15.3%) developed mild PIH. 
Three women (23%) had premature delivery and four babies (30.7%) were small 
for gestational age. Within this group there were two intrauterine deaths both 
involved one twin where the other twin suiwived.
3.3.9 Pregnancy outcome of cptestiofinaire non-respondents
It may be supposed that women who had no family histoi*y o f pregnancy 
hypertension would be less interested in the study and therefore less likely to 
return the questionnaire. As almost 10% of women entered into the study did not 
respond to the family history questionnaire and, as the overall incidence o f PIH 
amongst the women who returned questionnaires was low (14%), if the incidence 
o f PIH amongst women who did not return the questionnaire was significantly 
different from that o f the main sample this would suggest that the sample was 
biased by willingness or not to return the questionnaire.
Data on pregnancy outcome was therefore collected for 102 women who did not 
respond to the family history questionnaire, for comparison with the main study 
group.
Case records were missing for five women and complete data was available for 
97. There was one twin pregnancy within this group. The incidence o f PIH (table 
3.7) was higher in this group compared to the group who returned questionnaires,
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. .18.7% compared to 14% however this difference was not statistically significant.
Only one woman in this group had essential hypertension (1%) compared to 6.8%
in the main group. Comparing the degree o f hypertension (table 3.8), the
incidence o f mild PIH was similar in both groups (11.3% in the returned 
.questionnaire group and 11.4% in the non returned group). For moderate PIH the 
incidence was 5.2% in the non return group compared to 2.2% in the main group 
The incidence o f  severe disease was similar in both groups 2% in the non returned 
group compared with 1.4% in the main group. Numbers o f women who had 
moderate and severe disease, however were small in the non return group (five 
and two respectively).
In comparing obstetric outcome o f women in this group with that o f  the main
study group (table 3.9) there was no statistically significant difference in any o f  the
:outcomes reported although as before, the numbers in the non return group were Vi'V
small for some outcomes. Comparison o f the incidence o f  PIH and obstetric 
outcome between the women who did return their family history questionnaires 
and those who did not suggests that although the family histories o f the non return 
group cannot be known the pregnancy outcomes are similar and the sample does #
not appear to be biased on the basis o f non return o f the questionnaire.
:
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Table 3.7 Incidence o f hypertension in singleton pregnancies o f  women who did 
not return family history questionnaires
Diagnosis % number
Normotensive 80.2 77
PIH (includes mild, moderate and 18.7 18
severe)
Essential hypertension 1 1
Total 99.9 96
Table 3.8 Degree o f  PIH in singleton pregnancies o f  women who did not return 
the family history questionnaire (n=18)
Degree o f  PIH % (of total sample) number
Mild 11.4 11
Moderate 5.2 5
Severe 2.0 2
Antihypertensive therapy 7.2 7
____
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Table 3.9 Obstetric outcome in singleton pregnancies o f women who did not 
return family history questionnaires
Obstetric outcome normal
n=77
pm
n~18
essential 
hypertension 
n—1
intrauterine death 1 (1.2%) 0 0
Perinatal death 1 (1.2%) 0
Mean (SD) gestation at 3 9 (2 ) 39(2) 40
delivery in weeks
preterm delivery 6 (7.7%) 2(11.1% ) 0
<37 weeks
mean (SD) birthweight 3.16kg (0.61) 3.13 (0.52) 3.80
Small for gestational age 8 (10.3%) 3 (16.6%) 0
(<10th percentile)
Admission to SCBU 7 (9%) 2(11.1% ) 0
_____ 4%
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3.4 Comparison of results of questionnaire and pregnancy outcome with 
predicted results
Table 3.10 compares the results o f the family history questionnaire and pregnancy 
outcome o f respondents with the predicted results (table 2.1). There was a higher 
than expected number o f women who were excluded from the study after study 
entry, in addition there were 11 women who could not give information about 
their family history o f pregnancy hypertension, therefore there were only 879 
women for whom a prediction o f risk could be made on the basis o f family history. 
This was lower than the number anticipated in the power calculation. There was a 
higher than expected reported incidence o f  pregnancy hypertension in the family 
histories.
Within the sample, when women who had essential hypertension are excluded the 
overall incidence o f  PIH was 15% and this was in keeping with that predicted. 
Within the group o f  women who reported a family history o f  pregnancy 
hypertension we predicted that approximately 25% o f women would develop PIH, 
however, only 18.8% actually developed the disease (75/300 were predicted, 
60/318 developed disease), although this is a lower than predicted incidence the 
difference was not statistically significant. Within the group who reported no 
family history o f  pregnancy hypertension there was a slightly higher than predicted 
incidence o f  PIH, 12.8% compared to 10.7% predicted, however this difference is 
also not statistically significant. Although the overall sample size was lower than 
predicted, the incidence o f disease was similar between that predicted and the 
study sample. As the number o f  women who reported a family history o f  
pregnancy hypertension was high, it appears that the study sample size was 
adequate.
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3.5 Prediction of PIH
The questionnaire identified groups o f women by family histoiy these are 
summarised in table 3.11. The study population (n=890) represents the general 
population although as described above identifiable risk groups for development 
o f  PIH have been removed in order that the influence o f  family history o f  
hypertension may be more clearly identified. Within this study group the o f  
incidence o f PIH was 15%. Three family history groups were initially identified 
these were;
i) Women who reported a family history o f pregnancy hypertension.
ii) Women who reported a family history o f cardiovascular disease.
iii) Women who had no family history o f pregnancy hypertension.
There was higher than expected incidence o f family history both o f pregnancy 
hypertension (35.7%) and o f  cardiovascular disease (49.1%) and as might be 
expected, there was considerable overlap between these groups In attempting to 
identify the value o f family history in predicting women at risk o f developing PIH, 
comparison was first made between two simple groups which may be easily 
identified in the clinical setting. The first group were those who reported that a 
member o f their family (mother, sister, aunt or grandmother) had pregnancy 
hypertension, the second group comprised women who reported that no member 
o f their family had pregnancy hypertension.
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The sample was then further divided into more distinct family histoiy groups and 
these are compared with a presumed lowest risk group o f women who gave a 
family history in which there was apparently no hypertension or cardiovascular 
disease.
S. 5,1 Family history o f Pregnancy Hypertension as a predictor of PIH 
The presumed high risk group for the development o f PIH was identified by the 
questionnaire as the group o f  318 women who gave a family history o f pregnancy 
hypertension. This was compared with a presumed low risk group o f  561 women 
who reported that they had no family histoiy o f pregnancy hypertension ( table 
3.12). Within the group who reported that they had a family history o f  pregnancy 
hypertension 60 women subsequently developed PIH (18.8%), compared to 72 
women who subsequently developed PIH (12.8%) in the group who reported no 
such history. This difference is statistically significant. A  positive family history 
o f  pregnancy hypertension gives an odds ratio (OR) o f  1.58 (95% Confidence 
Limits (CL) 1.08-2.2). This implies that a woman who has a family histoiy o f  
hypertension in pregnancy will have a 58% increased chance o f  developing PIH 
compared to women who have no such family history.
__ ' A'-::
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Table 3.12 Comparison of the incidence of PIH in women with positive and
negative family history of pregnancy hypertension
Developed PIH Did not develop
pm
Total
Family history o f  
pregnancy hypertension
60 258 318
No family history o f  
pregnancy hypertension
72 489 561
Total 132 747 879*
‘'Total does not total 890 because o f  the occurrence o f  PIH amongst women who 
did not know their family history.
Prevalence = 0.15 
Sensitivity = 0.455 
Specificity = 0.655 
Positive Predictive Value = 0.189 
Negative Predictive Value = 0.872 
Odds Ratio = 1 .58
95% confidence interval
0.369 - 0.543 
0 .619-0 .688
1.086-2 .297  
(X^= 5.79; p < 0.05 )
I f
disease came from the negative family history group.
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However the use of family history of pregnancy hypertension only predicted 45%
of women who subsequently developed PIH, 55% of women who developed the
The same family history groups were again compared for the development o f mild, 
moderate and severe disease. Because o f  small number o f  women who developed 
severe PIH in the sample, the women who developed moderate and severe disease 
were considered together. In addition as a measure o f  clinical problem, the 
women who received treatment for PIH were also assessed as a group. 
Comparing development o f  mild disease (table 3.13), it can be seen that a positive 
family history o f pregnancy hypertension did predict for the development o f  mild
PIH giving an OR o f 1.56, but not for moderate and severe disease. Table 3.14 
compares the occurrence o f moderate and severe disease, the results show that 
although the OR was 1.47, the 95% confidence limits transcended unity, therefore 
this was not found to be significant. Table 3.15 demonstrates that women who 
reported a family history o f pregnancy hypertension were twice as likely to require 
treatment because o f  hypertension in pregnancy than those who reported no 
family history (OR 2.01, CL 1.06-3.8). It can be seen from the sensitivity that 
52% o f those requiring therapy were selected by the family history questionnaire.
;
I
83
Table 3.13. Comparison of the occurrence of mild PIH in women with positive
and negative family histories.
Developed mild 
PIH
Did not develop 
mild PIH
Total
Family history o f  
Pregnancy hypertension
46 272 318
No family history o f  
pregnancy hypertension
55 506 561
Total 101 778 879
Prevalence = 0.115 
Sensitivity = 0 .455  
Specificity = 0.650 
Positive Predictive Value = 0.145 
Negative Predictive Value = 0.902 
Odds Ratio = 1 .56
95% confidence interval
0.400-0.611  
0.488 - 0.571
1.00-2.41
(X^=4.33; p < 0.05 )
______  -
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Table 3.14 Comparison of the occurrence of moderate/severe PIH in women with
positive and negative family histories.
Developed mod/sev 
PIH
Did not develop 
mod/sev PIH
Total
Family history o f  
Pregnancy hypertension
14 304 318
No family history o f  
pregnancy hypertension
17 544 561
Total 31 848 879
Prevalence = 0.035 
Sensitivity = 0.452 
Specificity = 0.642 
Positive Predictive Value = 
Negative Predictive Value 
Odds Ratio = 1.474
0.044 
= 0.970
95% confidence interval
0.278 - 0.636 
0.608 - 0.674
0 .736-3 .031  (ns)
-a:
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Table 3,15 Comparison of the requirement for antihypertensive therapy in women
with positive and negative family histories.
Treatment for PIH Did not require 
treatment for PIH
Total
Family history o f  
pregnancy hypertension
21 297 318
No family history o f  
pregnancy hypertension
19 542 561
Total 40 839 879
!
J
I
•i
Prevalence = 0.046 
Sensitivity = 0.525 
Specificity = 0.646 
Positive Predictive Value = 
Negative Predictive Value 
Odds Ratio = 2.017
0.066 
= 0.966
95% confidence interval
0 .364-0 .681  
0.612 - 0.678
1.067-3 .812
(^2 = 4,836; p < 0,05)
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3.S,2 Identification of distinct family history groups 
Four distinct family history groups were identified these were;
i) Women who gave a family histoiy o f  cardiovascular disease but reported no 
family history o f pregnancy hypertension.
ii) Women who gave a family history o f cardiovascular disease and also a family 
history o f  pregnancy hypertension.
iii) Women who gave a family history o f  pregnancy hypertension but no family 
history o f  cardiovascular disease,
iv) Women who gave a completely negative family history both o f cardiovascular 
.disease and pregnancy hypertension.
3.5.2 Incidence o f PIH in the completely negative family history group 
The completely negative family history group consists o f  351 women who 
reported that they had negative family histories o f both cardiovascular disease and 
pregnancy hypertension. This completely negative group had the lowest incidence 
o f  PIH (11.1%), this was compared with those women who reported either a 
family history o f pregnancy hypertension or cardiovascular disease (Table 3.16) in
which the incidence o f  PIH 15%, this difference between these groups was 
statistically significant.
■Î:
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Table 3.16 Comparison of the outcome of pregnancy of women with a completely
negative family history with that of women with a history of pregnancy
hypertension or cardiovascular disease
developed PIH did not develop PIH Total
Family history o f  
pregnancy 
hypertension or 
CVD
95 444 539
All negative family 
history
39 312 351
Total 134 756 890
prevalence = 0.15 
sensitivity = 0 .709  
specificity =0 .413  
positive predictive value = 0.176 
negative predictive value = 0.889 
Odds ratio = 1.71
95% confidence interval 
0 .12 -0 .176  
0.623-0.782 
0.378-0.449
1,148 - 2.553 ( 7,053; p< 0.01)
______
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The ali negative group contains only 29.1% o f the women who subsequently 
developed pregnancy induced hypertension. A reported family history o f  
pregnancy hypertension or cardiovascular disease gives a 70% increased OR 
compared to the completely negative family history group (OR 1,71, CL 1.14- 
2.55) within this group. The completely negative group is therefore taken as the 
lowest risk group to compare the relative risks o f  any positive family history.
3.5.4 Comparison o f family history groups with the completely negative family 
history groups
Table 3.17 summarises the results o f  the comparisons o f  each family history group 
with the completely negative family history group. Compared with the completely 
negative family history group, a family history o f pregnancy hypertension gave a 
statistically increased OR both for all PIH and for mild PIH. As before, there was 
an OR o f around two for women who required treatment, but this did not reach 
statistical significance.
As may be expected the negative family history o f  pregnancy hypertension group 
was not significantly different from the completely negative family history group. 
A reported family history o f  cardiovascular disease did give an increased OR for 
all PIH and this was significant, but if those who also reported a family history o f  
pregnancy hypertension are removed from this group, the statistical significance is 
lost There is still a high odds ratio, but only related to the development o f  mild 
PIH.
'
' V- ' - :  ...         ‘
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Table 3.17 Odds ratio (OR) for development of PIH compared with the
completely negative family group.
Type Incidence OR Confidence Limits
Family history; all PIH 18.8 1.86 1.2 2.87 7.962*
pregnancy Mild 14.4 1.81 1.11 2.94 5.804**
hypertension Mod/sev 4.4 1.7 0.7 4.1 ns
Treatment 6.6 1.99 0.96 4.12 ns
Family history; all PIH 12.8 1.17 0.77 1.78 ns
no pregnancy Mild 9.8 1.16 0.71 1.90 ns
hypertension Mod/sev 3.0 1.18 0.52 2.69 ns
Treatment 3.3 0.99 0.47 2.06 ns
Family history; all PIH 16.9 1.63 1.07 2.47 5.372**
CVD Mild 12.1 1.47 0.92 2.36 ns
Mod/sev 4.81 1.91 0.86 4.24 ns
Treatment 5.4 1.64 0.8 3.33 ns
Family history; all PIH 16.1 1.53 0.93 2.52 ns
CVD no Mild 12.3 1.5 0.86 2.62 ns
pregnancy Mod/sev 3.8 1.49 0.56 3.94 ns
hypertepsion Treatment 3.3 0.96 0.37 2.50 ns
Family history; all PIH 17.4 1.69 1.01 2.81 4.58**
CVD Mild 12.3 1.51 0.84 2.71 ns
and pregnancy Mod/sev 5 2.02 0.76 5.39 ns
hypertension Treatment 7.7 2.38 1.11 5.10 5.332**
Family history; all PIH 22 2.25 1.26 4.02 7.890*
pregnancy Mild 19 2.51 1.34 4.68 8.781*
hypertension no Mod/sev 3.0 1.17 0.31 4.42 ns
CVD Treatment 4 1.17 0.37 3.73 ns
p< 0.01; »*p< 0.05
:4' :
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Where there is a history o f  both cardiovascular disease and pregnancy 
hypertension, the OR is 1.69. which is statistically significant for the development 
o f any PIH. The OR is not significant when degrees o f PIH are separated 
although it is significantly increased for those women who required therapy (OR 
2.38 CL 1.11-5.10).
If a family history o f  pregnancy hypertension only is considered, there is a 
statistically significant OR o f  over 2, but as before, this is only true for the groups 
o f  women who had any PIH and the mild PIH group. The OR was not 
significantly increased in the moderate/severe or the treatment groups.
3,5.5 History of pregnancy hypertension in specific family members
The questionnaire identified pregnancy hypertension in specific family members 
(mother, sister, aunt and grandmother) however the numbers in these groups are 
reduced especially for sisters where only 42% o f women had a sister who had 
been pregnant.. Data for each family member group was compared with the 
completely negative family history group (table 3.18) and they are significant only 
for sisters. Within this group the OR was significant for all types o f PIH. The 
most surprising results within this set o f data were the negative findings for the 
family history o f pregnancy hypertension in the mothers o f  women within the 
study sample. Only the results for the all PIH group have been presented for 
mothers, aunts and grandmothers as all the rest were similarly negative.
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3.5.6. Specific Cardiovascular Disease
The questionnaire identified reported family history o f  cardiovascular disease 
separated into essential hypertension, cardiac disease and stroke. As before there 
is overlap between the groups and numbers are reduced in particular for the group 
reporting family history o f  stroke (table 3.3). When data for reported family 
history o f  different types o f  cardiovascular disease history were compared to the 
completely negative family history group (table 3.18), both family history o f  
essential hypertension and cardiac disease increase the OR o f  all PIH but family 
history o f stroke did not. The essential hypertension group linked mostly with 
mild PIH (OR 1.97 CL 1.23-3.17) but cardiac disease links with moderate and 
severe PIH (OR 2.32, CL 1.01-5.33).
3.5.7 Personal history of essential hypertension
As a comparison, the OR for development o f PIH for the 65 women who were 
known to have essential hypertension were also compared to the completely 
negative family history group (table 3.18), showing increased OR for all types o f  
PIH but particularly the moderate/severe and treatment groups.
The group o f women who reported a history o f  renal problems were similarly 
compared, although as described above this group o f women did not appear to 
have renal disease on retrospective case record review. This group did not have 
an increased OR for development o f PIH
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3.5.8 Summary o f the comparison o f family history groups with the completely
negative family history group.
Comparing the OR for development o f PIH in women who report differing family 
histories o f pregnancy hypertension and cardiovascular disease with women who 
report no such history, there appears to be a link between reported family history 
o f  pregnancy hypertension and subsequent development o f PIH. This is mostly 
related to women whose sisters have been affected. A family history o f  essential 
hypertension appears to be related to mild disease rather than moderate/severe 
disease. The link between ischaemic heart disease and moderate/severe disease is 
interesting and merits further study. The findings from the group o f  women who 
had essential hypertension confirms the high risk nature o f  this group.
3.6 Comparison o f the odds ratio (OR) for family history groups with study 
population
If knowledge o f  a woman's family history o f pregnancy hypertension or 
cardiovascular disease is to be o f practical value in predicting her risk o f  
developing PIH, risk conferred by such history must be increased in relation to the 
general population rather than a lowest risk group. In order to test this, the family 
history groups defined above were compared to the total study group as proxy for 
the general population in which the incidence o f PIH was 15%.
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3.6.1 Comparison of OR of family history groups and the study population for  
the development of any pregnancy-induced hypertension
Comparing the OR o f  each o f the family groups with the total study population 
for the development o f any PIH (table 3,19), the only statistically significant 
finding was for sisters, and for women who themselves had essential hypertension. ■'
A family history o f pregnancy hypertension both with and without a family history 
o f cardiovascular disease demonstrate an increase OR although not at a 
statistically significant level. The completely negative family history group
showed a 30% reduction in PIH compared to the study population as a whole 
although this was not statistically significant.
3.6.2 Comparison of OR o f family history groups and the study population for 
the development of mild PIH
Comparing the same family groups for the development o f mild PIH (table 3.20) 
the OR was only found to be significantly increased for those women who 
reported that their sisters had been affected, women who reported a family history 
o f pregnancy hypertension but no cardiovascular disease, women who had a 
family history o f  essential hypertension and for women who themselves had 
essential hypertension. Within this group a simple family history o f pregnancy 
hypertension did not increase the OR significantly.
3.6.3 Comparison of OR of family history groups and the study population for 
the development of moderate/severe PIH
%
Comparing the same family history groups for the development o f moderate and 
severe PIH ( table 3 21), only the women who themselves had essential 
hypertension showed an increased OR compared to the study sample as a whole.
AA- '■ = .A 'A % A. -'/ A
A reported histoiy o f an affected sister did give an increased OR o f approaching 
two however this did not reacli statistical significance.
3.6.4 Comparison o f OR of family history groups and the study population for  
the requirement for antihyperlensive therapy
Comparing the family history groups for the women who required 
antihypertensive therapy (table 3,22) as with the moderate and severe groups the 
only group which demonstrated a statistically increased OR was the group o f 
women who had essential hypertension. There was an OR o f over two in the 
group with a family history o f affected sisters however, as before this was not 
statistically significant.
■-A*' _______
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4.1 Validity of data
The purpose o f this research was not to determine the value o f an accurate 
family history o f pregnancy hypertension in predicting the subsequent 
development o f pregnancy-induced hypertension (PIH) nor to test the 
accuracy o f a woman's knowledge o f her family history o f the condition. 
Rather, it was to determine whether information about family history o f  
hypertension in pregnancy or cardiovascular disease which could be 
provided by the woman herself would be o f value as a pragmatic predictor 
for the development o f PIH. In some respects this study has similarities to 
the retrospective family history studies into o f eclampsia and pre-eclampsia 
which pre-dated Chesley's systematic follow up o f women who had 
eclampsia (described in chapter one), in that it relies on information about 
family history o f hypertension provided by the women themselves, and 
there was no attempt to verify this information by review o f medical 
records.
Research o f familial tendency to PIH from the time o f Chesley's studies 
have used the method o f tracing medical records o f family members, 
applying specific diagnostic criteria based on blood pressure, proteinuria 
and parity, in attempting to obtain an accurate retrospective diagnosis o f  
PIH, pre-eclampsia or eclampsia. Although this method may encounter 
problems o f poor documentation within case records and differing 
terminology used over time, these studies have provided the most accurate 
information on the incidence o f PIH and eclampsia within families. The 
main problem in using this methodology is the difficulty in tracing the 
obstetric case records o f various family members. For this method to be 
used prospectively as a screening test for PIH it would be necessary to
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trace the obstetric case records for several family members for each 
primigravid woman booking at an ante-natal clinic.
This was considered impractical, particularly in the context o f the value o f  
such a history as a possible screening technique to identify women at higher 
risk. This study aimed to adopt a pragmatic approach by asking a series o f  
simple questions about family history o f  hypertension in pregnancy as well 
as cardiovascular disease and to test their value in predicting the 
development o f PIH. However, information provided by women about the 
medical history o f family members must be treated with some caution. 
Although the family history questionnaire appeared to provide accurate 
information on the woman's knowledge o f her family history, it is not 
possible to know how accurate this information would be in comparison 
with a review o f medical records.
The number o f "don't know" responses demonstrates, as might be 
expected, that women were able to give less information about more 
distant relatives (aunts and grandmothers) than about close family members 
(mother and sisters) However, even in relation to close family, the study 
relies both upon the understanding a family member will have about their 
own medical history and how accurately they will have passed that 
information on to the woman answering the questionnaire. Although the 
questionnaire differentiated between hypertension occurring in pregnancy 
and outwith pregnancy, it did not differentiate between first and subsequent 
pregnancies. The question, "did your mother have hypertension in 
pregnancy?" would therefore be answered in relation to the mothers total 
pregnancies, not just her first pregnancy. A women replying that a family 
member had pregnancy hypertension may have been identifying PIH or 
essential hypertension which also occurred in pregnancy. That there was a 
higher than anticipated reported incidence o f family history o f pregnancy
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hypertension (36%) suggests that this may have occurred. This is not 
surprising as in the clinical situation PIH can be difficult to differentiate 
from essential hypertension.
It must be assumed therefore that within this study a woman reporting a 
family history o f pregnancy hypertension is giving a mixed history o f  all 
types o f hypertension which may have occurred in the pregnancies o f a 
number o f family members.
4.2 Reported Incidence of family history of cardiovascular disease
The reported incidence o f cardiovascular disease within the sample was 
high (49.1%). The area in which the study was based is within the Greater 
Glasgow Health Board (GGHB) area, and includes several areas o f  
socioeconomic deprivation, where the standardised death rate (for people 
under 65 years) is twice that o f  people living in the most socioeconomically 
advance areas o f the city. Within the GGHB population two o f  the main 
causes o f death in people under 65 years are cardiac disease and stroke. 
The death rate for these conditions is 14% to 18% above the average for 
Scotland (GGHB, 1990). It would seen likely therefore, that the high 
incidence o f cardiovascular disease reported in this study reflects a true 
picture o f the incidence o f disease within the north and east o f Glasgow.
4.3 Incidence of PIH within the study
Within the study group the incidence o f PIH was low. Only 15% o f  
women developed any PIH with 11.3% developing mild, 2.2% moderate, 
and only 1.4% developing severe disease. This incidence is considerably 
lower than that described in the studies o f Campbell and MacGillivray 
(1985) however, it is more in keeping with the more recent studies 
(Alderman et al, 1986 and Kilpatrick et al, 1989) described in chapter one,
':':T'
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who reported an incidence o f severe PIH o f between two and three 
percent.
I
In addition, 42 women who had PIH (4.3% of the study population) 
received anti-hypertensive therapy and it would be reasonable to assume 
that these women had significant or progressive disease, although they 
could not be described as having severe PIH on retrospective case record 
review.
4.4, Prediction of pregnancy-induced hypertension
4.4. L Family history o f pregnancy hypertension
The familial tendency to develop PIH was apparent using the data obtained 
from the simple family history questionnaire, however, in applying the ■ ' ■'!
information as a screening test the data were more equivocal. Over one
third o f women reported that they had a family history o f  pregnancy 
hypertension. These women had an increased incidence o f PIH which was 
significantly higher than the group o f women who reported that they had
Ï
. :no such family history (18.8% verses 12.8%).
■The sensitivity and specificity o f this test were not high (45% and 65%
respectively), and the positive predictive value o f these questions was low  
(18.9%). Over 80% of women who were predicted positive on the basis o f  
having a reported family history o f pregnancy hypertension subsequently 
remained normotensive throughout their pregnancy (Table 3.12).
Although, in the study group as a whole the incidence o f severe PIH was 
low (1.4%), however, 4.7% o f women required antihypertensive therapy
and this may indicate that clinically they had significant disease. Women
I
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who reported a family history o f pregnancy hypertension were twice as 
likely to require antihypertensive therapy as those who did not (Table 
3.15).
4.4.2 Ideniification of the lowest risk group
The questionnaire did identify a group o f women who were least likely to 
develop PIH. These were the group o f women who reported that they had 
no family history either o f pregnancy hypertension or o f CVD. In 
comparison with this completely negative group, a reported family history 
o f CVD or pregnancy hypertension gave a sensitivity o f 70%, specificity o f  
41% and a negative predictive value o f 88%. Although this suggests that 
the completely negative group o f women are at particularly low risk 11% 
subsequently developed PIH, 3.4% required antihypertensive therapy.
4.4.3 Comparison with other screening tests
In comparing the results o f this study with other screening tests for PIH 
account must be taken o f the differing incidence o f disease in study 
populations as well as the divergent results reported for many o f the tests 
by successive studies, A reported family history o f  pregnancy 
hypertension, compared to women who reported no such family histoiy 
provides broadly similar results to other non-invasive screening tests such 
as the roll-over test and the measurement o f mid-trimester blood pressure. 
The measurement o f mid-trimester blood pressure (Moutquin et al, 1985) 
in predicting pre-eclampsia in a population where the prevalence was 5%, 
demonstrated a sensitivity o f 86% (compared to 45% in the current study), 
specificity o f 50% compared to 65% and a positive predictive value o f 10% 
compared to 18% in the current study. The roll-over test however, gave a 
sensitivity o f only 10% and a specificity o f  90% with a prevalence o f  
disease o f 19% (Turnbridge and Donnai, 1983).
' : ' ' ' i—
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The results o f the family history questionnaire do not compare well to tests 
such as angiotensin II infusion, which has demonstrated a specificity o f  
91% (Gant, 1973) This test is invasive and complex to perform however, 
and so is unsuitable as a screening test for application to the general 
pregnant population.
4.4.4 Comparison with the study population
Although comparison o f positive with negative family history groups forms 
an interesting statistical comparison, o f  more relevance in a clinical 
situation is the comparison o f incidence o f PIH in a woman who reports a 
family history o f pregnancy hypertension with the incidence in the general 
population. After exclusion o f women who had essential hypertension the 
incidence in the study population was 15% and this was taken as the 
background incidence for comparison.
In considering the comparison between family groups and the study 
population as a whole, identification o f OR for development o f disease is o f  
more value than specific test indices such as sensitivity, specificity, positive 
and negative predictive values. This is because the groups are not mutually 
exclusive, comparison is made between incidence in women with an 
affected sister and the total study group rather than with women who do 
not have an affected sister. Although these comparisons give less 
statistically significant results they were thought to be more clinically 
meaningful.
When family history groups were compared with the study population only 
a reported history o f pregnancy hypertension in a sister gave a significantly 
increased odds ratio (OR) for the development o f any or mild PIH.
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Although there was also an increased OR for the development o f  
moderate/severe PIH where a sister was affected, compared to the study 
group, this was not significant.
Within this study, a reported family history o f a sister who has had 
hypertension in pregnancy provided the best predictor for the development 
o f PIH. However, less than half o f women sampled had a sister who had 
been pregnant and this restricts its value as a predictor for PIH. 
Nevertheless, a women who has a sister who has had hypertension in 
pregnancy appears to be at particular risk o f developing PIH.
Twenty per cent o f women reported that their mother had an affected 
pregnancy, this proved to be a poor predictor for the development o f  PIH. 
The incidence o f any PIH, as well as that o f mild, moderate and severe 
disease was no higher in women who reported that their mother had 
pregnancy hypertension than in the study population.
How do the results o f this study compare with those o f other studies? 
Chesley et al (1961, 1962, 1968) took a group o f eclamptic women as the 
index cases for a prospective study which investigated the incidence o f  
eclampsia and pre-eclampsia in daughters, daughters-in-law, sisters, 
granddaughters and granddaughters in law. This study found the highest 
incidence o f severe pre-eclampsia or eclampsia in sisters o f index cases 
(37%) and an increased incidence in daughters compared to daughters in 
law (26.2% and 6.1% respectively). The data o f  Chesley et al (1961, 1962, 
1968) agrees with that o f the current study in that the incidence o f PIH 
where a sister had an affected pregnancy was also high compared to the 
study population (28.5% and 15% respectively). However in contrast, the 
current study did not find an increased incidence o f PIH in the reported
___________________
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histories o f either mothers or grandmothers when compared to the study 
population.
Adams and Finlayson (1961) also compared the incidence o f pre-eclampsia 
in sisters o f pre-eclamptic index cases, women who developed hypertension 
which could not be classified as pre-eclampsia and normotensive controls 
reporting a higher incidence o f pre-eclampsia in sisters o f who had pre­
eclampsia compared to controls (13.8% compared to 4.5%)
i |
Although Chesley et al (1961, 1962, 1968) and Adams and Finlayson
(1961) report different incidences o f pre-eclampsia in relatives studied,
both demonstrated a high incidence o f disease in sisters o f affected women.
.The current study also demonstrated an increase o f over two-fold in the
'S'
incidence o f severe disease (1.4% in the study population compared to 
3.57% where a sister was reportedly affected), although the incidence o f 
severe PIH overall was very low.
I
Cooper and Liston (1979) analysed the data of Chesley et al (1961, 1962, 
. . .1968), combining new data with that o f Adams and Finlayson in an attempt 
.to identify the genetic model o f inheritance for pre-eclampsia. The 
combined data found a higher incidence of severe pre-eclampsia amongst 
mothers o f index cases than in sisters (22,8% and 15.9%). Although these 
results could not conclusively identity the genetic model o f inheritance, 
they confirm the high incidence o f pre-eclampsia in both mothers and 
daughters. As before these data agree with those o f the current study in 
relation to sisters but not for mothers. /
Sutherland et al (1981 )compared the incidence o f pre-eclampsia in mothers 
.and mothers in law o f women who had severe pre-eclampsia as index cases
$ 
j;"
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and normotensive women as controls. This study confirmed the results o f 
the previous study finding a higher incidence of pre-eclampsia in mothers 
of index cases (14%) than in mothers in law o f index cases (4%) and 
mothers and mothers in law o f controls (3% and 4% respectively). This 
was again in contrast to the results o f the current study which found no 
greater incidence o f PIH in women who reported that they had an affected 
mother.
Arngrimsson et al (1990) used as index cases women who had severe pre­
eclampsia or eclampsia, tracing medical records o f daughters and 
granddaughters and using daughters-in-law and granddaughters-in-law as 
controls. This study again confirmed a high incidence o f pre-eclampsia in 
daughters compared with controls (23% compared to 10%). However in 
relation to granddaughters this study found that there was not a 
significantly higher incidence o f pre-eclampsia compared to controls. This 
contrasts with data o f Chesley et al (1961, 1962, 1968) who found an 
increased incidence o f  disease in granddaughters, however it is in 
agreement with the current study which found that the incidence o f PIH in 
women who reported that they had an affected grandmother was not higher 
than the study population.
All o f these studies agree that there is an increase incidence o f pre­
eclampsia in mothers or sisters o f eclamptic or pre-eclamptic women 
although the reported incidence varies in each study. Data from the current 
study concurs with the findings o f these studies in relation to sisters, 
although the magnitude o f the increase is much less. This suggests that 
women were able to provide the most accurate information about their 
sisters' pregnancies, although even this group will contain all types o f 
hypertension occurring in pregnancy. The contrast between the results of
'.w v.. ..
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this study compared to other studies in relation to family history o f 
pregnancy hypertension in mothers suggests that, although the mother is a 
close relative, the questionnaire did not give sufficient information on the 
mother's history o f pregnancy hypertension.
The study population were primigravid women, their sisters are likely to be 
o f similar ages and may have had only one or two pregnancies, thus a 
reported history o f pregnancy hypertension is likely to relate to 
hypertension in a first or second pregnancy, and to be true PIH. However, 
mothers o f respondents will be older and presumably have completed their 
reproductive years. Therefore a woman reporting that her mother had 
hypertension in pregnancy will be reporting hypertension which may have 
occurred in any pregnancy. This may include PIH but also gestational 
hypertension which may indicate a tendency to develop essential 
hypertension. This may explain the lack of association between reported 
maternal hypertension and the development of PIH in women.
4.4.5 Mild or severe PIH
Comparison o f family history groups with the lowest risk group suggested 
that there did appear to be a link between a reported family history o f 
pregnancy hypertension and the development o f mild PIH. This link was 
also present in comparison to the study population, where there was an 
affected sister, and where there was a family history o f essential 
hypertension. Overall the questionnaire did not identify family history 
groups which would predict the development o f moderate and severe 
disease except in relation to affected sisters where it found an increased 
incidence of moderate and severe disease, and this was significant in 
comparison to the lowest risk group. This contrasts with other family 
history studies cited which have consistently demonstrated a strong familial
I l l
link with severe disease. However, the methodology o f these studies differ 
from the current study in that they used, as index cases women who had 
severe disease (either eclampsia or pre-eclampsia) and trace, either 
prospectively or retrospectively the incidence o f disease in relatives.
These studies used similar numbers o f normotensive women, or "in-laws" 
as controls. The current study in contrast took as its starting point a group 
o f primigravid women, normotensive at outset o f pregnancy, and attempted 
to predict their risk o f developing PIH through their reported family 
history. Most o f these women remained normotensive throughout 
pregnancy only a very small number developing severe PIH (n-13). The 
lack o f predictive value in relation to severe disease may be partly 
explained by the small number o f women in the severe PIH group.
Several studies have suggested that mild and severe PIH are inherited as 
different entities. Adams and Finlayson (1961) found that sisters tended to 
develop similar types o f hypertension in pregnancy (42.2% developed 
hypertension and 9.4% pre-eclampsia in the sisters o f  women with 
hypertension, compared to 34.4% hypertension and 13.8% pre-eclampsia 
in the sisters o f pre-eclamptic women). Although the incidence o f any 
hypertension was higher in sisters o f women who had either hypertension 
or pre-eclampsia than that o f the general population. The authors 
suggested from this finding that pre-eclampsia and hypertension are 
independent conditions.
Cooper and Liston (1979) investigated the incidence o f mild and severe 
pre-eclampsia amongst mothers and daughters o f mild and severe index 
cases. They found the incidence o f mild disease was highest in relatives o f
112
mildly affected index cases, although only in the data o f Adams and 
Finlayson (1961) was this statistically significant.
Sutherland et al (1981), compared the incidence o f mild pre-eclampsia in 
the mothers and mothers-in-law o f index cases who had severe pre­
eclampsia and normotensive controls. Their results showed that although 
there was a higher incidence o f mild pre-eclampsia in the relatives o f the 
index cases compared to the controls, this was not statistically significant. 
The authors support the previous studies in suggesting that mild and severe 
disease are different pathological entities, inherited differently.
Although any hypertension which occurred in the pregnancies o f women 
responding to this questionnaire was clearly defined, the reported family 
history o f pregnancy hypertension within this study will have included both 
mild and severe disease. Therefore the types o f pregnancy hypertension 
present in the family history o f women who subsequently developed either 
mild or severe PIH cannot be differentiated.
There is a higher incidence in the general population o f mild than severe 
disease and therefore, correspondingly, there must be a higher incidence o f 
a history o f mild disease, which is thought to have a tendency to predispose 
to later development o f essential hypertension, or to reveal a latent 
tendency to develop hypertension which may only manifest in later life.
That the questionnaire was more successful in predicting the development 
o f mild PIH probably reflects a familial tendency to develop mild disease 
and the larger number o f women who will have a family history o f  mild, 
compared to severe, PIH.
t
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It must be assumed that the questionnaire did not elicit sufficiently specific 
information on type o f pregnancy hypertension within the family history in 
order to predict the very small number of women who developed severe 
PIH within this study.
The results suggest that there is a familial tendency to develop both mild 
and severe PIH however, from this data it is not possible to say whether or 
not they are independent entities.
4.4.6 Influence o f Cardiovascular disease
This study suggests that there is influence o f a family history o f  
cardiovascular disease on the development of PIH, although as discussed 
the study was carried out in an area where there is a particularly high 
incidence o f cardiovascular disease in the general population and this may 
have influenced the results.
The data were separated into groups o f women who reported family 
history o f both pregnancy hypertension and cardiovascular disease, 
pregnancy hypertension alone and cardiovascular disease alone. Where 
only cardiovascular disease was reported there was no increased OR for 
the development o f either mild or moderate\severe disease.
The group who reported a history o f pregnancy hypertension alone had a 
significantly increased OR but solely for development o f  mild PIH (tables 
3.17 and 3.20). Only where there was also a reported family history o f  
cardiovascular disease was there an increased OR for the development o f  
moderate\severe disease although this was not statistically significant 
(Table 3.17).
______________________ _______
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In considering the influence of specific cardiovascular disease the data I
s
■.suggest that a reported family history o f essential hypertension is related to 
the development o f mild disease ( tables 3.18 and 3.20). Where there is a 
reported history o f cardiac disease however, there is a significantly 
increased OR for the development o f moderate\severe disease (table 3.18).
Other studies have investigated the influence of family history o f essential 
hypertension on incidence o f PIH but not that o f other cardiovascular 
disease.
Chesley et al (1968; 1986) compared the incidence o f pre-eclampsia in the 
sisters and daughters o f eclamptic index cases and found that it was not 
affected by whether or not the index women subsequently developed 
essential hypertension. The authors conclude that familial incidence o f  pre­
eclampsia is independent from the tendency to develop essential 
hypertension. Adams and Finlayson (1961), measured the blood pressure 
of mothers o f women who had pre-eclampsia and o f siblings o f women 
who had previously had pre-eclampsia and normotensive controls. They ■i
found, in contrast to the previous study that there was a greater incidence 
o f hypertension in later life in mothers and in siblings o f women who had 
pre-eclampsia than in those o f the control group. This paper concluded 
that pre-eclampsia does not cause hypertension in later life but develops in 
women with an inherited hypertensive tendency. I
The current study suggests that there is a link between a family history o f  
.essential hypertension and the development o f mild PIH but in the 
development o f moderate and severe disease there is influence o f a family 
history o f cardiac disease. The absence o f an increase o f severe disease in 
women who reported only a family history of pregnancy hypertension, and 
the increased OR for development o f moderate\severe disease in the group
-
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with both cardiovascular disease and pregnancy hypertension, could 
suggest that although a family history o f pregnancy hypertension is 
important in the development o f any PIH there is influence from a family 
history o f cardiovascular disease in the development o f more significant 
disease.
4.5 Essential hypertension
Investigating the outcome o f pregnancy in women who had essential 
hypertension was not a primary objective o f the study, however the 
questionnaire highlighted a group of women who either had essential 
hypertension or who gave a history o f hypertension. This study confirmed 
that these women were at particular risk o f subsequently developing 
superimposed PIH. This group had the highest incidence o f  severe disease 
(9.23%) within the study and 21.5% required antihypertensive therapy.
A woman who gives a history o f hypertension should be considered at high 
risk o f developing PIH, even where her blood pressure is normal at the 
time o f booking, especially where no first trimester blood pressure is 
available.
4.6 Conclusion
The high response rate to the questionnaire used in this study shows that it 
is feasible to obtain simple family history information from pregnant 
women who attend an ante natal clinic. Women were not, however, 
prepared to answer a very detailed questionnaire, the pilot study o f a 
larger, more complex family history questionnaire was unsuccessful.
It must also be acknowledged that the information obtained by this method 
is limited, the responses may give an account o f a woman's understanding
________________________________________ __
I
116
o f her families history in relation to hypertensive disorders generally but it 
should not be presumed to separate specific types o f hypertension which 
may occur in pregnancy.
The questionnaire did highlight both higher and lower risk family history 
groups for the subsequent development o f PIH. The highest risk group 
was that where a sister had been affected. In this group the incidence o f all 
types o f PIH were highest o f all family history groups. Although, the 
number o f women who had a sister who had been pregnant and therefore, 
had opportunity to be tested for the development o f PIH was low.
The lowest risk group identified was the women who reported that they 
had neither family history o f pregnancy hypertension nor cardiovascular 
disease and these women had the lowest incidence o f PIH within this study. 
Although these higher and lower risk groups were identified, within the 
highest risk group the incidence o f severe disease remained low and most 
women remained normal throughout pregnancy. Within the lowest risk 
group although the incidence o f PIH especially severe disease was low it 
did occur in some women. Based on these data the family history did not 
appear to be o f value in the clinical setting as a screening test in predicting 
the development o f PIH.
Should pregnant women be asked routinely about their family history o f  
hypertension in pregnancy? In spite o f the disappointing results o f this 
study in relation to prediction o f PIH this would appear to be good 
practice, as women both at increased or reduced risk may be identified in 
this way. In addition, it may be o f value to ask about family history o f  
cardiovascular disease, in particular heart disease as this appears to have 
some impact on the development o f severe PIH. This information may be
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o f clinical value as part o f risk analysis for individual women at outset o f  
pregnancy.
A woman who reports that she has a sister who has been affected by 
hypertension in pregnancy may warrant additional attention to blood 
pressure around the end o f the second trimester o f pregnancy. However, 
information on family history o f pregnancy hypertension or cardiovascular 
disease which may be provided by the women themselves does not justify 
altering clinical practice, toward the broad groups o f women identified, 
either to increase monitoring for the highest risk group or to decrease 
vigilance toward the lowest risk group.
This study did confirm the need for particularly careful monitoring o f  
women who present with essential hypertension or give a past history o f  
hypertension, as these women were clearly at risk o f developing severe 
superimposed PIH (9.2% o f women in this group developed severe PIH).
Numerous studies concur that there is a strong familial tendency in the 
development o f  PIH, however, it is not, at present, feasible to utilise this 
information as a screening test at least partly because women do not have 
sufficient information about their family history.
Although it is good practice to routinely enquire about family history, this 
study highlights the importance o f ensuring that women who develop PIH 
have accurate information about their condition which may be passed on to 
relatives if required.
At present the only economical, feasible screening available for PIH is the 
routine antenatal measurement o f blood pressure which has been offered to 
women since 1928. If the gene or genes responsible for development o f
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PIH were identified this may provide the basis for cost effective screening 
for PIH. There is a need to develop linkage studies between disease genes 
and marker genes. These studies require family histories o f at least two 
generations with affected women. Although this questionnaire did not in 
itself prove o f value as a screening test for the development o f PIH its 
particular strength was its simplicity. It was economical to apply to a large 
study population, it was non invasive and acceptable to most women. A  
simple family history questionnaire may be a useful preliminary contact in 
identifying families in which women have been affected by PIH. These 
families could then be targeted for more detailed examination in pedigree 
studies.
The data highlighted several questions about the aetiology o f PIH. It 
would be interesting to further investigate the postulated familial tendency 
to develop similar types o f hypertension in pregnancy.
Further study is required into the apparent influence o f cardiovascular 
disease in the development o f PIH. In particular, the connection between a 
family history o f essential hypertension and the development o f  mild 
disease. In addition, fiirther study is warranted into the apparent link 
between a family history o f cardiac disease and the development o f severe 
PIH.
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